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IF-
If you can keep your head when all about you 
Are losing theirs and blaming it on you,
If you can trust yourself when all men doubt you, 
But make allowance for their doubting too;
If you can wait and not be tired of waiting,
Or being lied about, don’t deal in lies,
Or being hated, don’t give way to hating, 
And yet don’t look too good, nor talk too wise:
Rudyard Kipling.
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The major aim of this thesis was to explore alternative synthetic routes to the 
Jaborandi alkaloid pilocarpine, which could subsequently be applied to an 
asymmetric synthesis of (+)-pilocarpine. Recent interest in this relatively “old” 
drug stems from a depletion of its natural source making necessary a synthesis, 
preferably in chiral form.
The initial approach involved attempted coupling of
1 -me thy limidazol-5-yl-lithium with 3-toluenesulphonyloxymethyl-4-butanolide. 
This did not succeed because the lithioimidazole species could not be formed.
The second approach was based on the alkylation of 
1 -methyl-5-ethynylimidazole with ethyl 2-bromobutyrate. The initial target, 
l-methyl-5-ethynylimidazole, was prepared by a nine-step synthesis but proved 
to have very toxic side-effects. The desired alkylation step did not succeed 
because of side-reactions due to branching of the alkyl halide used.
The toxicity of the imidazolylalkyne prevented further work with it, so an 
alternative route involving the Michael addition of
l-methyl-5-(l,3-dithianyl)imidazole to 2(5H)fiiranone was attempted. Literature 
precedents for such reaction appeared good; however no 1,4-addition product 
could be recovered.
The fourth route employed the Wittig reaction as its key step, involving ethyl
3-methylenephosphoranylbutanoate. However, both model chemistry and the 
envisaged strategic reaction failed to give the desired results.
1
The penultimate approach centred on ring-opening of
l-methyl-5-oxiranylimidazole, a previously unknown compound, with the anion 
of ethyl butanoate, which was to be followed by several manipulations. These, it 
was envisaged, would afford access to a selenide which would cyclise (in the 
presence of azobisisobutyronitrile and tributyl tin hydride) to give pilocarpine. 
Again problems of severe toxicity were encountered in preparation of the 
epoxide, rendering further work on these imidazole systems inadvisable.
The final route involved, once again, the use of an alkyne key intermediate to 
facilitate a radical cyclisation which would form the lactone unit of pilocarpine. 
Here a convergent synthesis, using butyn-l,4-diol as starting material, was used 
to build up the lactone and imidazole fragments at opposite ends of the alkyne 
functional group. The key step involved nucleophilic attack by nitromethane 
anion on the imine unit of the monoprotected 2-butyn-4-(tetrahydropyranyl)-l-al. 





“Come forth into the light of things,
Let nature be your teacher.”
W. Wordsworth.
11 . Occurrence and Isolation.
Pilocarpine (1) occurs in plants of the Jaborandi family and most abundantly in 
the Pilocarpus genus, which originates from Brazil. The chemistry and 
pharmacology of pilocarpine were first investigated in the nineteenth century. In 
1875 Gerrard1 and Hardy,2 working independently, obtained the alkaloid from 
P.jaborandi extracts, after fractional crystallisation of its mineral acid salts. 
Samples were supplied to other laboratories for biological assessment.
Although other natural products are also present in the extracts, only pilocarpine 
is medicinally important. It is used for the treatment of glaucoma, nephritis and 
Alzheimer’s disease.
The absolute stereochemistry of the pilocarpine molecule is shown in Figure 1, 
together with the numbering system used to describe it. Only the cis- 
arrangement of the lactone side-chains is of interest; isopilocarpine (2), the 
trans-isomer, is essentially inactive biologically. Very early on, Jowett3 showed 
that pilocarpine decomposes readily, in aqueous solution, to the more 
thermodynamically favourable trans-isomer* isopilocarpine’s lack of activity is 
therefore unfortunate.
Currently, all pilocarpine in clinical use is obtained from plant sources, especially
3
(+) pilocaipine (+) isopilocarpine
Figure 1.
from P.mircophyllus.5 However, there are at least nine syntheses to the alkaloid - 
none of which are asymmetric, due to facile epimerisation of the lactone.6 So, at 
the present time, the natural source is still economically viable.
1*2 Structure Elucidation.
Considering its long history, it is not surprising that the structure of pilocarpine 
was largely determined by classical methods; i.e. degradation and part synthesis. 
The stereochemistry of the molecule was a source of difficulty to early chemists, 
who were unable to explain the difference between pilocarpine and 
isopilocarpine. Furthermore, they noted features in common between both 
molecules. For example, one of the two nitrogen atoms present was tertiary, in 
both isomers, and salts of molecular formula C11H160 2N2.RX were formed by 
alkylation of either isomer with alkyl halides (RX).7
Treatment with alkali gave salts which, when carefully acidified, reformed the 
alkaloids.3 Less attention to the conditions of these experiments often led to the 
isomerisation of pilocarpine. From the behaviour in alkali-acid a lactone function 
was indicated, but the imidazole nucleus was not recognised. Therefore, 
representations such as the pyridine derivative (3) were considered,8 even though 
this structure has only one stereocentre and could not encompass both pilocarpine
(3)
and isopilocarpine.
An advance was reported by Jowett9 who degraded pilocarpine, via oxidation 
with potassium permanganate, into homopilopic acid (4) and homoisopilopic acid 
(5). Similar treatment of isopilocarpine gave homoisopilopic acid (5) and 




this work. Jowett9 later proved that homoisopilopic acid was formed from both 
pilocarpine and isopilocarpine. The structures of the products obtained from these 
degradation studies were worked out by interconversion with known 
compounds,11 although the relative and absolute stereochemistries were unknown 
at that time. However, the lactonic nature of such oxidation products lent support 
to the existence of a cyclic ester function in the natural alkaloids. Its presence
5










Heating isopilocarpine with soda lime produces ammonia and methylamine, 
together with three other bases. One of these is 1-methylimidazole, and the others 
are apparently l,4(5)-dimethylimidazole and "pentyl-l-methylimidazole.9 From 
this experiment, Jowett provided evidence for the nature of a second heterocyclic 
ring and its substitution pattern.
The structure of pilocarpine still could not be elucidated completely. It was not 
possible to deduce whether the dimethylimidazole group, present in the original 
molecule, was 1,4- or 1,5-disubstituted. This problem was eventually solved by 
Pyman.12 He carried out further degradation studies on 1,4- (or 1,5-) 
dimethylimidazole, which Jowett had obtained from isopilocarpine. Nitration of 
this imidazole, and subsequent reduction with stannous chloride, gave 
(±)-N-methylalanine (10). This result allowed the characterisation of Jowett’s 
base as 1,5-dimethylimidazole (8), since similar reaction of 
1,4-dimethylimidazole (11) would produce unmethylated (±)-alanine (13) - a fact 
verified by experiment.
Even so, well respected chemists, such as Pinner,13 argued that pilocarpine and 
isopilocarpine were the structural isomers (14) and (15) - an idea which ignored 
the facile nature of their interconversion.6 Again it was Jowett14 who came to the
Me
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lactone sidechain stereochemistry.15 Later, Prebrathenski16 suggested that the 
less stable alkaloid pilocarpine has the cis- arrangement; whereas the 
trans-isomer is isopilocarpine.
1-3 Stereochemistry.
However, the question of the absolute stereochemistry of pilocarpine remained 
open until 1963. In that year Nagarajan et a lP  showed that homoisopilopic acid 
(5), on reduction with hydrazine and borane, followed by treatment with lithium 
aluminium hydride, gave (+)-2,3-diethyl-1,4-butane-1,4-diol (17). They were able 
to determine the absolute configuration of both (+)-/r<ms-2,3-diethyl-4-butanolide 








Starting from the (-)-butanolide (16) and tryptamine, they prepared 
(-)-16a-strychindol (18) - a degradation product of strychnine - the structure of 





they could assign the absolute stereochemistry of butanolide (16). Later X-ray 
diffraction analyses of pilocarpine trichlorogermanate (II) hemihydrate confirmed 
the cis- orientation of pilocarpine directly.19 This X-ray data also verified that the 
cis- arrangement is the less stable one for pilocarpine. Since that time more 
structural evidence, including that drawn from synthesis, has been accumulated; 
and it complements the earlier work.20"24
8
1-4 Isomerisation of Pilocarpine to Isopilocarpine.
It has been shown that heating an aqueous solution of pilocarpine causes a 
structural change.25'27 In 1968 Dopke and d’Heureuse28 indicated that 
isomerisation of pilocarpine is not necessarily caused by opening of the lactone 
ring, but could result from epimerisation via the enolate (Scheme 1).









R = CH2Imidazole 
Scheme 1.
Later Nunes and Brochmann-Hanssen29 proposed two pathways for the 
degradation of pilocarpine. These involved either hydrolysis30 of pilocarpine to 
pilocarpic acid, or epimerisation; both result in loss of pharmacological activity 
(Scheme 2).
Further work with i.r.,31 h.p.l.c.32 and n.m.r.33 techniques confirmed that 
epimerisation is more significant than hydrolysis.
As pilocarpine has been used extensively in ophthalmology, methods have been 
developed to determine the rate of epimerisation to isopilocaipine in aqueous 
solution. These include thin layer chromatography,34 electrophoresis,35 
potentiometry with ion-selective membrane electrodes36 and gas-liquid














chromatography.37 Of these, high performance liquid chromatography38 is the 
most advantageous - due to its high sensitivity (down to 0.1 jig), and applicability 
to direct analysis of aqueous pilocarpine solutions used in ophthalmology.39
1-5 Biosynthesis.
Relatively few alkaloids are known which incorporate the imidazole ring; and, of 
these, it appears that only pilocarpine is of medical significance. As the structures 
of pilocarpine and histidine bear considerable resemblances to one another, it was 
thought that a histamine derivative could be a biosynthetic precursor of the 
imidazole unit in pilocarpine. For example, in 1955, Robinson40 published a 
proposal for the origin of pilocarpine. He suggested that reaction between 
0-phosphoryl-5-(3-hydroxy-2-oxopropyl)imidazole (21) and two molecules of 
either acetate, or a four-carbon unit such as butyrate or acetoacetate, was 
involved (Scheme 3). The product (22) could then undergo lactonisation and 






VJ  = biologically-occurring phosphate group
u
NMe
Scheme 3. Robinson’s biosynthetic pathway.
Robinson’s idea was later elaborated by Boit41 and Leete 42 It was considered 
that a carbon-carbon43,44 bond-forming reaction is preceded by O-acylation. 
Thus, it is suggested that the co-enzyme A thioacetoacetic acid (or its equivalent) 
reacts with phosphate (21) to afford the ester (24). Subsequent cyclodehydration 
occurs, via an intramolecular aldol reaction (Scheme 4). These ideas have 
parallels in the biosyntheses of digitoxigenin and histidine.
In 1975, Nunes5,45 proposed a second biosynthetic pathway to pilocarpine. It 
involves the amino acid threonine, and is based upon an aldol condensation, 
followed by esterification (Scheme 5). Experimental work has been performed, 
involving feeding 14C radio-labelled compounds to plants. These studies suggest 
that pilocarpine is synthesised in the roots of Pilocarpus species, and that 
N-methylation - thought to be the final step - occurs in the leaves. However, it 




















Pilocarpine is an old drug46 which has been widely studied for its action in the 
central nervous system (C.N.S.) and elsewhere. It is widely used to counteract the 
mydriatic effect of atropine 47 and for the treatment of glaucoma.48'50 Other uses 

















Since pilocarpine has such a profound effect upon the parasympathetic nervous 
system, it has been considered as a chemotherapeutic agent against Alzheimer’s 
disease.53
There is interest in determining the relationship between pilocarpine and 
established neurotransmitting agents, such as acetylcholine (34). The latter 
compound is released from the presynaptic cleft and received at a receptor site on 
the other side of the synapse. At this postsynaptic site, it serves to acetylate a 
hydroxyl group of a serine residue. (9-Acetylation is rapidly followed by 
hydrolysis, so that the hydroxyl group is re-established ready to receive the next 
“message”. In the course of this process, acetylcholine is itself cleaved to form 
choline and acetic acid. Although acetylcholine is not a chiral molecule, the 
receptor site is, and acetylcholine is required to adopt a specific conformation 
within the receptor pocket.54,55
Me
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Changes to the structure of acetylcholine will alter the accessibility of this 
conformation,56'58 and it has been noted that some of its derivatives have 
different biological properties. Dale59 has shown that molecules such as nicotine 
and muscarinic acid act as agonists and antagonists of acetylcholine. Such a 
response implies that different types of receptor sites occur within the nervous 
system. These are now called nicotinic and muscarinic receptors; the former are 
located at neuromuscular junctions in autonomic ganglia, and the latter occur in
14
the parasympathetic target organs.60
Muscarinic receptors have been subdivided into further categories, Mj, M2 and 
M3. It is noted that modifications to acetylcholine61 may activate its response 
within one or another of these sites. In general, muscarinic compounds tend to 
slow the heart beat, cause reduction in blood pressure,62 and show depressor 
activity; while nicotinic compounds have the reverse effect.
In the case of Alzheimer’s disease^  post mortem investigations have shown a 
loss of acetylcholine within the neurons of the brain (down to 30% of normal 
levels). This is thought to be one of the factors responsible for the condition. It 
has been found that Alzheimer sufferers exhibit an approximate 20% decrease in 
the number of M2 receptors.63b M2 receptors are believed to modulate the release 
of acetylcholine. However, the receptors are more highly concentrated in the 
brain than are M2, and are believed to be important in the thinking process. Thus 
the development of a selective M i agonist is of appreciable importance. The 
structures of some cholinergic64 agonists are shown in Figure 2.
Physostigmine (39) has shown the most encouraging results against Alzheimer’s 
Disease, improving the memory of sufferers. The major disadvantage is its short 
half life, a common feature of most chemotherapeutic methods used against this 
disease. All the compounds shown in Figure 3 contain nitrogen atoms which can 
be protonated, or are already quaternary, like acetylcholine itself. Another 
common feature is an electrophilic group, most often a carbonyl function (ester or 
amide) at a specific distance from the potential quaternary centre. The 
complexity of this problem is exaggerated by the fact that specific structural 
requirements are not fully understood for the more important two subdivisions of 
































Most known cholinergic agonists have short half lives in vivo, lack specificity,65 
and are poor at permeating the blood brain barrier. They also have adverse 
















population, senile dementia is a pressing problem world-wide; most 
pharmaceutical companies have significant programmes of research in this area.
The structural relationship between muscarine and pilocarpine is not as clear cut 
as might have been expected. Distances between “significant” atoms in the two 
molecules do not correlate very well. Nevertheless, the molecules seem to 
engender similar responses in v/vo,51,66-68 due to hydrolysis and formation of a 
quaternary nitrogen. (Figure 4).
1*7 Syntheses.
The first synthesis of pilocaipine was reported by Preobrashenski et al.69-78 These 
authors concentrated on building up the imidazole nucleus late in their procedure. 
Ethyla-formy 1-a’-ethylsuccinate (43) was reduced to the corresponding alcohol
(44), which was hydrolysed and lactonised to give a mixture of (±)-pilopic and 
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An Amdt-Eistert homologation of (+)-pilopic acid (45) thus obtained gave 
(+)-homopilopic acid (4), (Scheme 7). The homologation procedure was 
repeated, affording the diazoketone (49), (Scheme 8). Treatment of this 
compound with potassium thiocyanate produced the imidazole (50), which was 













methylated by reaction with dimethylsulphate. Sadly, this last reaction displays 
no selectivity and two mono-TV-methyl compounds were formed. Additionally, 
partial isomerisation to isopilocaipine was noted.
Deys79 approach also adopted homopilopic acid as the first key intermediate. 
Several steps from ethyl 4-ethoxy-2-butenoic acid afforded the racemic acid, 
which was converted into the ketone (52), Scheme 9. An aldol condensation 
between this substrate and benzaldehyde, followed by ozonolysis afforded the 
ketoaldehyde (53). Treatment of this with ammonia and formaldehyde gave 
racemic imidazole (31). Again, the question of regioselective iV-methylation was 
not addressed. Instead, pilocarpine, isolated from the products of a non-specific 
methylation, was resolved via its tartrate salt (Scheme 9).
Two other syntheses, by Chumachenko80,81 and by Degraw,82 are essentially 
variants on the earlier approaches already outlined. Starting from furfural, a 











In 1972, Link and Benauer83 envisioned another route, this time from
5-formyl- 1 -methylimidazole (55), which was obtained from the corresponding 
methyl ester(54).84 By starting from a //-methylated imidazole precursor these 
authors solved, for the first time, the lack of regioselective control inherent in 
previous syntheses (Scheme 10). A Stobbe reaction upon the aldehyde gave the 
potassium salt of the mono-esterified diacid (56). Following reduction and 
cyclisation, this compound afforded pilosine (58). Reaction of its enolate anion 
with ethyl acetate produced ketone (59), which was reduced to the racemic 
alcohol epimers (60). Dehydration and catalytic reduction afforded 
(±)-pilocarpine.





















ij E t02CCH2C 02Et,
ii; EtI, iii; Hydrolysis, iv; HBr
v; SOCl2, vi; MeZnI,
vii; PhCOH, NaOH, viii; 0 3, 
ix; NH3, CH20 , x; Me2S04.
Scheme 9.
typical overall yield is 0.1% of pilocarpine. Thus, Noordam85,86 was led to utilise 
commercially available L-histidine as his starting material. That choice was made 
favourable because of Bergermann’s definition of selective 1-N-methylation 
conditions for the imidazole nucleus87,88 (Schemes 11 and 12).
In Noordam’s synthesis, L-histidine was first converted into
(S)-2-hydroxy-3-(imidazol-5-yl)propionic acid (63) using silver nitrite and 































with 4-nitrobenzenesulphonyl chloride; effecting sulphonation of the alcohol 
function and the 3-N-position of the imidazole ring. Presumably the latter 












v ,  VI H2N^ NMe
HCK x O N
i; C6HjCOC1, ii; MeOH, H+,












H O ^ ^ o  N
i; (Imid)2 CO, ii; Mel, 
iii; HC1.
/ ^ N  
Imid = — N ^ ^ J
Scheme 12.
bearing the sulphonate group was achieved using lithium bromide. Methylation 
of the sulphonamide (66) with Meerweurs salt afforded the N-methylimidazole
23
(67). Next, this was alkylated, by treatment with the anion of dibenzyl 
ethylmalonate, to yield triester (68). Hydrogenolysis afforded the diacid (69), 
which was decarboxylated to produce the epimeric monoacids (70). Reduction 
with lithium borohydride and acidification of the products gave pilocaipine (1), 
and isopilocaipine (2) in a 1:1 ratio (Scheme 13).
RO MeO
Br H
N u N ] ' > - N
MeO
(62) X = NH2, R = H
(63) X = OH, R = H




(65) R1 = p-N02PhS02 (66) Rl = p-N02PhS02
Br
NMe . NMem IV
MeO MeO
(68) R = PhCH









i; /?-N02PhS02Cl, ii; LiBr, iii; Me3OBF4, iv; (RC02)2CHEt, v; H2 , Pt, 
vi; 140°C, vii; LiBH4, viii; 2M HC1
Scheme 13.
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It is difficult to see why the monoacids (70), or suitable derivatives, were not 
separated; since in principle this should have avoided the lack of selectivity.
In 1986 Rapoport and Compagnone89 described a synthesis which incorporates 
the use of D-methionine (73) as the chiral starting material. The use of this 
compound has the advantage that the C-3 and C-4 stereocentres of pilocarpine are 
accessed early (Scheme 14).
Desulphurisation of D-methionine by treatment with Raney nickel gave the amino 
acid (75), which was reacted with nitrous acid and potassium bromide to afford
v.
2-bromobutanoic acid (77). Esterification produced terf-butanoate (79), which 
reacted with reagent (80) to give the phosphonate (96). A Homer-Emmons type 
reaction between this compound and 5-formyl-l-methylimidazole then gave 
unsaturated cyanoester (82). The cyanide function of this compound was then 
converted in two steps into the alcohol (88).
Rapoport and Compagnone anticipated that alcohol (88) would predominantly 
adopt the conformation shown in Scheme 15, thus catalytic c/j-hydrogenation 
would afford the saturated hydroxyester (93). When treated with trifluoroacetic 
acid, this compound should give pilocarpine (1). However, the actual products 
were the hydroxyester (91) and isopilocarpine (2) (Scheme 14). Reaction of 
silylated alcohol (88) also led to hydrogenation in the same sense as for the free 
alcohol; indicating that hydrogen bonding was not involved in stabilising the 
relevant conformation. Rapoport and Compagnone concluded that the observed 
sterospecificity resulted from spatial demands arising from the steric bulk of the 
rm-butyl ester grouping. The result was that epimerisation was required to 
complete the synthesis of pilocarpine (1).
25
R1
(72) R1 = NH2, R2 = H (74) R1 = NH2, R2 = H (76) R1 = Br, R2 = H




E t O \
EtO '  cO j’Bu
NH" (55)
(81) R1 = Et, R2 = H




(83) R1 = Et, R2 = H
(84) R1 = H, R2 = Et
Only E-isomer undergoes reduction 
hv
(78) R1 = Br, R2 = H
(79) R1 = H, R2 = Br
C O ^ u  N
(87) R1 = Et, R2 = H
(88) R 1 = H, R2 = Et
CC^Bu
(85) R1 = Et, R2 = H






i; Raney Ni, ii; NaN02, KBr, H+, iii; isobutylene, H2S04, iv NCCH2PO(OEt)2 = 
(80), v; KH, l-methyl-5-formyli midazole = (55), vi; Raney Ni, NaH2PO(OEt)2, 










i; Pd, C, H2, ii; CF3C 02H 
Scheme 15.
1*8 Analogues of Pilocarpine.
With such an important biological profile, it is obvious that a search for 
analogues of pilocarpine would be actively pursued.90 As early as 1912, Jowett91 
synthesised the imidazoles (94) and (95) and found that they were inactive. In 
fact, later work on ring-opened analogues showed that all had little or no
(94) (95)
muscarinic activity.92 Of all the analogues made to date, those containing the 
lactone show the greatest effect.
Mutschle and Woo93 have produced a ring opened derivative (96), which shows 
only marginal activity when compared with recent cyclic analogues such as the 






The analogue of pilocarpine (98) having an N-methyl group at the 3-position95 is 
inactive. Loss of activity also occurs if the methylimidazolyl96 side chain is 
relocated to C-3 of the lactone ring, as in compound (99). Similarly, omission of 
the lactone ring, or its presence in ring-opened form,97 causes inactivity. 






C >  o i Jo
(99)
Hanssen98 found that only tertiary amines (100) and (102) possess some activity, 




(100) R | = Me, R2 = Me 1 „ = 1 ,2
(101)R1= R 2 = Et i
mN 
H /  
R2
—  R1
(102) Rl = R? = Me
n =1, m= 2
Quatemisation of the imidazole unit,99,1.00 by alkylation with lower alkyl halides,
28
depresses muscarinic activity. This has been attributed to an increase in steric 
bulk, because activity is seen to fall in the series of salts from (103) to (105). 
Such a conclusion must remain tentative, since the ionic species are clearly much 
more lipophobic and may not cross cell membranes.
R
(103) R = Me (106) R = p-BrPhCH2
(104) R = nC4H9 (107) R = 3,4-Cl2PhCh2
(105) R = kyH n (108) R = p-BrPhCOCH2
On the other hand, N-benzylation101 promotes a change from muscarinic to
anticholinergenic activity. The effect is augmented, as in the series of compounds 
(106) to (108), by para-substitution of the aryl ring with substituents such as 
bromine, chlorine or methyl.
Numerous other analogues have been synthesised, all of which show little or no 
muscarinic activity.102' 106 Modifications have also been made to the size of the 
aromatic ring and the lactone.107 The former has been replaced by a pyrimidine, 
or pyridine, system; e.g. (109). Interestingly, of these compounds, only
4-pyrimidyl derivative (109) shows any activity. The lactone has also been 
substituted by the cyclopentanone unit, as in the series (110) to (113).
The presence of a carbonyl group in the oxygenated ring also seems to be 
necessary for muscarinic action, since the tetrahydrofuran108 (114) has a 
hypertensive effect. When it was administered intravenously to mammals, rapid 
cardiac arrest occurred due to a fall in blood pressure.
Interestingly, the lactams108 (115) (R = H, Me) also cause hypertension - which 
cannot be modified by the administration of atropine. It therefore appears that the
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(109) (110) R = H, X = 2-pyridyl
(111) R = Et, X = 2-pyridyl
(112) R= H, X = 4-pyridyl









extent of electron depletion at the carbonyl carbon atom is an important factor. 
Similarly, the thio analogues,109 e.g. thiolactone (116), of the pyrimidyl 
compounds are inactive. Inactivity was thought to arise from sulphur being less 
electronegative than oxygen, and thus reducing binding to the receptor. The 
increased C-S-C bond angle, which might lead to a distortion in the lactone ring 
size, may also reduce binding through steric hindrance.
Attempts have been made to prepare conformationally restricted analogues110 
such as (117). These would provide more information about the structural
30




One may conclude that the topology of the pilocarpine molecule seems to fit very 
precisely into the muscarinic receptor. Thus, only very closely related 
compounds, such as the oxazolidinone94,111 derivative (97), show comparable 
activity. The most recent analogue to be reported in the literature111 is a cyclic 
urea (118), but its activity has not yet been determined.
— NMe
o V  V
(97)
IH R ,  NR V J
Y  No
(118) R = Et or *Bu
1-9 Aims of the Research.
The physiological activity of pilocarpine5 has long been known, and has resulted 
in a gradual depletion of the natural supply. Recently, resources have been almost 
exhausted and so a new asymmetric preparation is required. No existing approach
to this alkaloid is completely asymmetric; so our intention was to develop a short, 
enantioselective, synthesis of pilocarpine.
In approaching this goal, we considered the disconnection shown in Scheme 16 - 




Tos = p-MePhS02 X = Li
Scheme 16.
this route is its potentially facile access to the target molecule. Both key 
intermediates, the lactone (119) and imidazoles (120), X = H and X = Hal, are 
known,112,113 so we would rapidly be able to address the key-step of coupling 
5-lithiated IV-methylimidazole with 3-(toluenesulphonyloxymethyl)butanolide; as 
detailed in Chapter 2.
However, for the synthesis to be asymmetric, chirality would need to be 
preserved at the centre a- to the carbonyl group of lactone (119). Unfortunately, 
the conditions reported113,114a for lithiation of imidazole (120) are extremely 
basic, and metallation is required to enable the key reaction of this synthetic 
approach. We therefore realised the necessity of investigating milder conditions, 
and recognised that we might still be unable to prevent a degree of racemisation. 
Nevertheless, we felt that the simplicity of this approach, if successful, would 
justify the work involved.
Our reservations about the methodology depicted in Scheme 16 prompted a 
consideration of alternative disconnections. We required an approach which
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would minimise the risk of racemisation, addressing this issue early on.
Therefore the exclusive use of mild conditions would be required towards the end 
of the synthesis. Furthermore, we required a much greater degree of 
stereochemical control during those later stages. Our second strategy, outlined in 
Scheme 17 and elaborated in Chapter 3, takes account of these considerations.
NMe NMe
(121)
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(125) X = Li
The key step is a selenide-mediated lactonisation onto an alkyne, which proceeds 
via a radical mechanism. The ring-closure is of the 5-exo dig type and is favoured 
by Baldwin’s rules;115 similar reactions have been achieved by Bachi and 
Bosch.116a
Successful cyclisation would result in an exocyclic double bond (the only 
structural feature differing from pilocarpine) a- to the chiral centre of lactone 
(121). It seemed probable that subsequent hydrogenation would afford a high 
degree of enantioselectivity. We expected approach of the catalyst to be governed 
by the stereochemistry of the ethyl group adjacent to the alkene. If so, this 
reduction would induce the desired stereochemistry at the second asymmetric
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centre in pilocarpine, and complete our chiral synthesis.
The only relatively harsh conditions, involving a chiral substrate, are involved in 
the coupling of bromoester (123) or (124) with the lithiated alkyne (125). Not 
only did we anticipate the conditions of this reaction to be controllable, but the 
reaction occurs early in the sequence. It is known117 that there are two possible 
mechanisms for such a reaction, depending upon the conditions employed, as 
shown in Scheme 18. At high concentrations of nucleophile, the reaction would
OR + NMe






proceed by direct SN2 attack at the bromide centre. However, with a lower 
presence of lithiated alkene (which should also minimise the chance of 
racemisation), anchimeric assistance by the ester function occurs. The effect of 
these successive nucleophilic inversions is that the reaction proceeds with overall 
retention of stereochemistry. Therefore, the choice of conditions involved will 
determine the use of (S)-bromoester (123) - which can be made from 
(S)-methionine - or (R) bromoester (124), which is available from 
(R) -me thionine.8 9
34
CHAPTER 2
2. EARLY LACTONE CONSTRUCTION AND ATTEMPTED COUPLING 
REACTIONS VIA 5-IMIDAZOLE FUNCTIONALISATION.
2 1  Introduction.
The imidazole unit is widespread in biological molecules; being found principally 
in amino-acids such as histidine (62) and its decarboxylation product, histamine 






Histidine residues frequently occur in enzymes, where they appear to function as 
catalysts for proton-transfer processes. Imidazoles are particularly important in 
this context, because they can serve as both acids and bases.118 Free imidazole is 
a moderately strong base, pKa 7-0, and a weak acid, pKa 14-5.
It has been shown119 that the most acidic proton of the imidazole molecule is at 
C-2. Despite the higher acidity of H-2, in our work it was important to achieve 
selective 5-functionalisation of the imidazole - otherwise difficulty in separating 
the resultant isomers was likely. Therefore, the necessity of protecting the 
2-position was anticipated.
Considering access to the butanolide (119), shown as a retrosynthesis in Scheme 




Kazusuke112 and modified by Tocanne and Asselineau.120 In this work it had 
been shown that 3-hydroxymethylbutanolide (128) could easily be prepared from 
diethyl succinate; see Schemes 19 and 20. The tosylate (133) appeared to be a 
good substrate to test the coupling reaction outlined in Scheme 16, and a simple 
modification would afford the lactone (119); i.e. resolution, vinylation and 
catalytic reduction. There was also the second option of delaying vinylation, a- to 
the carbonyl function, until after the coupling reaction had occurred. This could 
be advantageous, since no easily racemisable chiral centre would be present 




THP = 2-tetrahydropyranyl (119)
In Mori’s synthesis it was noted that a racemic mixture results at the paraconic 
acid (132) stage of the preparation of the butanolide. Resolution can be achieved 
with (R)-(+)-a-phenethylamine, affording a salt which, on filtration, gives 
optically pure (R)-paraconic acid.
Knowing acid (132) could be resolved relatively easily, we chose to test our 
methodology on the racemate in the first instance. Should our racemic synthesis
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be successful, the use of chiral materials would test the implementation as a 
stereospecific route to pilocarpine. Reduction of paraconic acid would give us the 
corresponding alcohol (128), and reaction with toluenesulphonyl chloride should 
yield the sulphonate (133) (Scheme 20). Access to the imidazole (120) was not 
expected to be a problem; see Scheme 16 in Chapter 1.
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We used Tocanne and Ansselineau’s synthesis120 of the butanolide (128), and 
formylated diethyl succinate (129) using ethyl foimate and two equivalents of 
sodium metal. This reaction resulted in the formation of aldehyde (130), which is 
a colourless oil, after purification by distillation (see Scheme 20).
n.m.r. spectroscopy showed this product is a tautomeric mixture in which the 
enol form predominates over the keto in a ratio of 2:3. The hydroxyl proton of the 
enol resonates as a doublet at 5 11 - 30, and this proton is exchanged by treatment 
with D20 . A second doublet, at 8 7 00, is the signal of the a-allylic proton which 
becomes a singlet after the D20  addition. The relative complexity of the n.m.r. 
spectrum is due to the presence of a chiral centre a- to the formyl group, thus the 
methylene protons are nonequivalent and exhibit geminal coupling (J = 12 Hz) 
and vicinal coupling ( /  = 6 Hz).
Reduction of aldehyde121 (130) with sodium borohydride in 98% ethanol was 
slower than expected, and this probably reflects the fact that the equilibrium 
favours the enol form of the compound. Indeed, in the alkaline media, the enolate 
anion could be present. Given sufficient reaction time, however, the yield of the 
alcohol (131) obtained was a respectable 80-90%. We formed the acid (132) by 
refluxing the alcohol (131) in 2M aqueous potassium hydroxide, which effected 
both hydrolysis and lactonisation. Crystallisation from chloroform gave 
(±)-paraconic acid (132). It was noted that reactions on quantities of the diester
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(131) greater than 5 g were not practical. The initial product was a sticky gum, 
which could not be readily purified. Below this amount, however, the reaction 
proceeded in 60-70% yield to afford a colourless crystalline product. Physical 
data were as anticipated; for example, the resonances of the protons of the 
methylene groups of acid (132), again showed geminal coupling - as befits their 
nonequivalence.
Treatment of paraconic acid (132) with borane dimethylsulphide122 gave
exclusively 3-hydroxymethylbutanolide (128) - although the yields were not
particularly good (32-38%). This was disappointing and, although our efforts
were not exhaustive, we did not improve upon the conditions and results quoted
 ^ ,•
in the literature.
In an attempt to overcome the low yield of this reaction, we sought to prepare the 
lactone (128) by a shorter route which a Japanese group123 have recently 
reported. Three equivalents of sodium borohydride were used to reduce the 
aldehyde (130). It was stated by these authors that this excess of reagent also 
results in the reduction of one of the ester groups. They suggest that there is a 
neighbouring group effect from the hydroxymethyl group, which arises from 
initial reduction of the aldehyde. A borohydride species, bonded to the oxygen 
atom of the incipient hydroxyl function, then delivers hydride regiospecifically to 
one of the ester groups. Sodium borohydride is normally insufficiently potent, 
under the reaction conditions used, to reduce an ester group.
Attempts to repeat this work by the author were only marginally successful, and 
gave inconsistent results. However, it became clear from the data we obtained 
that at least three products were produced - as a direct result of incomplete 
reduction. Because of the basic nature of the reaction mixture, we suspected that
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one of the products was paraconic acid. This was confirmed by mass 
spectrometry and by 1H n.m.r. spectroscopy, and in addition, the other two 
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We discovered that attempts to purify the lactone (128) by chromatography over 
silica led to large losses of material. We suspected that the relatively high 
retention time of this compound extended its residence time on the silica long 
enough to catalyse an appreciable degree of lactone ring-opening. This 
suggestion is supported by the fact that the chromatographic purification of the 
silyl ether124 of the alcohol (128) was much more efficient. The ether is much 
less polar and was rapidly eluted from the stationary phase, which improved 
yields by 20%.
Having obtained workable quantities of the lactone (128), we were able to 
attempt tosylation of its hydroxyl function. Thus a reaction of the alcohol (128) 
with toluenesulphonyl chloride, in pyridine solvent,125 afforded the tosylate 
(133), but only in 10% yield. Since tosylation activates hydroxyl groups by 
providing a good “leaving” unit, this result is perhaps not surprising. Indeed, 
there are many literature examples of loss of product125 during O-tosylation of 
alcohols. We noted that all the starting material was consumed during our
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We now felt it prudent to investigate the regiospecificity of 5-lithiation of 
1 -methyl-5-imidazole (120), X = H or X = Hal. We were also concerned to 
explore the nucleophilicity of the lithiated species, by the use of model chemistry. 
Further effort in optimising the synthesis of the tosylate (133) would seem to be 
wasted were the coupling of imidazole (120), X = Li, found to be inefficient.
2-3 Functionalisation of the 5-position of l-methylimidazole.
We were aware of the reports of several groups;126,127 that direct 5-lithiation of 
l-methylimidazole, to give exclusively one isomer, is almost impossible. There 
are two problems; the pronounced acidity of the imidazole proton at C-2, which 
prompts preferential reaction at this site. Also, where this is not an issue, a 4(5) 
mixture often results, which is difficult to separate.
It is well known128 that proton abstraction from C-2 of the imidazole ring is a 
facile process and occurs 104-105 times faster than the exchange of either H-4 or 
H-5,129,130 Scheme 21. Reactivity at C-2 towards electrophiles has also been 
suggested to involve the initial formation of a ylide species, arising from 
deprotonation of the protonated imidazole. Possible resonance stabilisation of this 
ylide by a carbene form has been proposed by Cohen and co-workers,130 although 
the nature of the carbene has not been demonstrated. The stability of the anion, it 
is argued, is due to the inductive influences of the two adjacent nitrogens, which
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also weaken the C(2) bond in the first instance.
There are two approaches which overcome the undesired reactivity of C-2. 
Firstly, it should be possible to protect this site prior to attempting deprotonation 
at C-5. Secondly, an imidazole synthesis may be performed which incorporates 
functionality at the desired site before completion of the imidazole skeleton. For 
example, preparation of a 5-halogenated 1-methylimidazole, followed by 
metal-halogen exchange, might be appropriate for our requirements.
It has been reported elsewhere131 that H-5 is the next most acidic proton.132 
Therefore, after blocking the 2-position8 of a //-substituted imidazole, the 
addition of a second equivalent of base generally produces an anion at C-5.119 It 
was hoped that 1-methylimidazole would behave in this way, and thus permit 
direct functionalisation of the 5-position. Other workers have blocked the 2- and
4-imidazole positions,133 using a wide variety of functional groups including 
thiophenyl, and trimethylsilyl.134 Iddon,113 has reviewed this subject.
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Germane to our strategy was the ease of deprotection at C-2. Unfortunately,
many potentially useful groups;131 but Iddon has recently shown that 
l-methyl-2-(trimethylsilyl)imidazole can be prepared,114 albeit in low yield , and 
that the silyl group can subsequently be displaced easily. We selected the 
'butyldimethylsilyl group, because its derivatives are generally more stable than 
the trimethyl silyl analogues, and attempted to form the C-silylimidazole 
(139)(Scheme 22).
Lithium di-isopropylamide (LDA) was formed at 0 °C, and cooled to -78 °C, 
after 90 minutes. A THF solution of 1-methylimidazole was added slowly, and 
stirred for a further 90 minutes, before fm-butyldimethylsilyl chloride in THF 
was added. It was observed that two compounds formed in a 4:1 ratio. The major
inappropriately forcing conditions are often required to achieve deprotection of
2) tBuMe2SiCl
(120) 
X = H 1) 2 Eq. LDA
\2 ) 2 Eq. tBuMe2SiCl
(138)
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" ^ Me Scheme 22 .
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9) LDA = lithium di-isopropylamide
component was the 2-silylated methylimidazole (138), and the minor was the 
2,5-disilylmethylimidazole (139). This result confirms that H-5 is the second 
most acidic proton in the molecule, as expected.
Repetition of the experiment, using two equivalents of lithium di-isopropylamide 
and 2.5 equivalents of rm-butyldimethylsilyl chloride, produced significantly 
more of the disilyl species (139). This particular disilyl species has not been 
reported elsewhere, and was found to be very unstable and hygroscopic. Overall, 
this was a good result since it showed that it should be possible to selectively 
protect C-2 and then to form the anion at C-5.
Thus the mono silyl imidazole (138) was prepared in situ, as previously, and a 
second equivalent of lithium di-isopropylamide was added. As a model reaction, 
an equivalent of benzyl bromide was then added in an attempt to produce the
5-benzyl derivative (141). However a clean reaction was not observed and t.l.c.
analysis (1:4 ethyl acetate-light petroleum (b.p. 60------80 °C) showed that a total
of six compounds were formed. The major component of the mixture had the 
same Rf as benzyl bromide. This was isolated, and characterised as fra/is-stilbene
(141), resulting from self-condensation and dehydrohalogenation of the bromide 
(Scheme 23). The remaining components could not easily be identified, as only 
trace amounts were obtained. However, it was possible to detect the presence of a 
small quantity of l-methyl-2-/butyldimethylsilylimidazole (M++ 1 = 197) but none 
of the desired product (140) was observed.
Thus it seems that the imidazole C-5 anion acts as a base towards benzyl 
bromide, rather than as a nucleophile. In this case the benzylic anion would form 
which then reacted with more benzyl bromide ultimately yielding stilbene. This 
caused us to consider that if the tosylate (133) was used as the electrophile, these 
conditions would ionise the rather more acidic protons a- to the lactone carbonyl 
group, and thus negate our plans.
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C-5.114a The required l-methyl-5-chloroimidazole is fairly accessible, and both 
the lithiated imidazole and the formation of the corresponding Grignard reagent 
seemed practicable.
A general procedure has been reported135*139 for the synthesis of 
1-methyl-5-haloimidazoles, using diethyl oxalate (142) as starting material.135 
A//-dimethyloxamide is generated on addition of methylamine to diethyl oxalate
(142), giving excellent (99%) yields of A^V-dimethyloxamide (143).140 This 
compound was then heated with phosphorus pentachloride to give
l-methyl-5-chloroimidazole (120), X = Cl.
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Godefroi and his co-workers135 suggested a mechanism for this reaction 
involving a di-imine (144) as an intermediate. This, they believe, undergoes a 
1,3-hydride shift, followed by cyclisation to imidazole (120), X = Cl, through , 
what is a 5-endo trig reaction; not favoured, according to Baldwin’s rules.115 The 
concept of a hydride shift is implausible, under the acidic conditions, and is more 
likely to be a prototropic isomerisation. Nevertheless, the observed product does 
indicate that a disfavoured cyclisation does occur (Scheme 24). Baldwin’s rules 
are predominantly based on considerations of topology and the accessibility of 
suitable transition states at “low” temperatures. However, Godefroi’s reaction 
conditions require heat and so less favourable geometric arrangements are 
possible. In addition, entropic factors also favour the ring-closure, elimination of 
hydrogen chloride serves to increase the disorder of the system.
The same procedure was also applied to the synthesis of the 5-bromo derivative. 
The major difficulty with such preparations is the solubility of the product in 
water. An aqueous base work-up is necessary, and this has a significant impact on 
the yields which are only 45-50%. According to Kochergin,141 better yields of the 
corresponding chloro derivative may be obtained by the use of phosphorus 
oxychloride in place of phosphorus pentachloride. However, we were unable to 
duplicate this result.
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Godt136 and Kochergin141 to our best advantage by heating phosphorus 
pentachloride with N^-dimethyloxamide (144). Extraction still tended to be a 
problem as a result of the water solubility of the halo compounds. Evidence of 
formation of the 5-chloro compound (120), X = Cl, came directly from the *H 
n.m.r. chemical shifts.
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Having prepared the 5-chloro compound, (120), X = Cl, we were able to 
determine the ease with which metal-halogen exchange could be achieved. 
Initially, we used one equivalent of lithium di-isopropylamide as base, in an 
attempt to form 2-lithiated l-methyl-5-chloroimidazole (120), X = Li. After 2 
hours at -78 °C, the reaction was quenched, with *butyldimethylsilyl chloride, and 
allowed to warm to room temperature. However, many components were seen to 












LDA = lithium di-isopropylamide
Scheme 25.
This result is in contrast to the relatively facile formation of
2-ferf-butyldimethylsilyl- 1-methylimidazole. Clearly the required anion is 
formed under these conditions, but it may then react with both the silylating agent 
and the chloroimidazole. Interestingly, when the base was changed to "butyl 
lithium the desired product 2-'butyldimethylsilyl-5-chloro-1 -methylimidazole 
(146) was formed and in high yield. There was no evidence for metal halogen 
exchange since none of the disilylated compound (139) was obtained. The 
reasons for this are obscure.113 (Scheme 26).
Chromatography over silica gel afforded the silyl compound (146), together with 














mixture.142 It is thought that partial hydrolysis may have occurred on the silica, 
resulting in loss of the silyl group. This is supported by the fact that imidazole 
(146), when stored in contact with air at room temperature, undergoes 
de-silylation to afford the starting material within three days.
Addition of a second equivalent of "butyl lithium at -78 °C, and subsequent 
quenching with D20 , did not result in incorporation of deuterium at the
5-position. We were surprised to see such complete failure of the reaction; but it 
is in accordance with literature reports. Five equivalents of "butyl lithium are 
reportedly required to facilitate metal-halogen exchange for
5-bromo-1-methylimidazole.143 Employment of such conditions would 
undoubtedly lead to ring-opening of the lactone in the coupling step. Benetti et 
al1AA have shown that treatment of lactones with an excess of lithium aryl species 
leads to high yields of open-chain products, and we confirmed that an analogous 
reaction occurs with 2(5H)-fiiranone and "butyl lithium, as shown in Scheme 27.




all the remaining positions on the imidazole ring have been functionalised, as in 
the case of 4-bromo-l-ethoxymethyl-5-methylthio-2-phenylthioimidazole (147).
-70 °C and quenching with dimethylsulphate gives methylation at the 1 and 4 
positions.
We felt our failure to induce metal-halogen exchange using the 
silylchloroimidazole (146) could be attributed to the strength of the C-Cl bond. 
The process appears to be more facile with the bromide or iodide. However, 
attempts to prepare the bromo compound (120) X = Br (by an analogous route) 
led to a small quantity of product and higher oligomers. These could not be fully 
characterised, but were tentatively thought to have the formula (C4N2H4)n-HBr, 
resulting from the stepwise displacement of bromide by the imidazolyl unit. 
Iddon supports145 this result and states that “attempts to exchange the bromine 
atoms for lithium in l-methyl-5-bromoimidazole failed”.
He also reports145 that treatment of 4(5)bromoimidazole with "butyl lithium at
Br
After the failure of the metal-halogen exchange reaction, we sought to investigate 
the reactions of the corresponding Grignard reagent, if it could be formed. In 
most aromatic systems Grignard compounds are readily produced from the aryl 
halide, and we had no reason to suspect that imidazole (120), X = Cl, would 
behave differently. We reacted imidazole (120), X = Cl, with magnesium metal 
and planned to quench it with benzoyl chloride. Indeed the Grignard reagent 
appeared to form easily enough, but when the ether solution was treated with 
benzoyl chloride only dibenzoyl was recovered. No starting material was 
observed, suggesting that perhaps the imidazole ring had been reduced133 and 
removed on aqueous extraction (Scheme 28).
It is thought that dibenzoyl formation occurs via a radical mechanism, in a similar
of magnesium.
The failure of the desired coupling reaction, in our model chemistry, did not
PhCOCl









fashion to the initial stages of the pinacol reaction,146 as proposed in Scheme 29. 
There is a literature precedent,147 for an analogous reaction with lithium in place
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inspire us to expend further effort on this route. Instead, we turned our attention 
to the second retrosynthetic strategy, which is detailed in Chapter 3.
CHAPTER 3
3. CONSTRUCTION OF THE LACTONE AT A LATER STAGE.
3*1. Introduction.
As with our previous attempts, we again sought to construct the lactone ring late 
en route to pilocarpine. Many routes exist for lactonisation via free radical 
mechanisms; including intramolecular addition of alkoxythiocarbonyl free 
radicals to acetylenes,148 palladium dihalide mediated closures onto 
acetylenes,149 and intramolecular cyclisation of allylic propiolates mediated by 
stannyl radicals.150 For a full review on lactonisation reactions involving radicals, 
see the paper by Surzur and Bertrand.151
In our study, we wished to take advantage of the selenide-mediated ring-closure 
onto an acetylene which is shown in the retrosynthesis outlined in Scheme 17 of 
section 1*9. Inspiration for this comes from an earlier report by Bachi and 
Bosch.116 These authors had shown that when tributyl tin is reacted with 
selenocarbonate compounds a carbonyl radical is generated. This species 
subsequently undergoes a 5-exo dig ring-closure onto an adjacent alkyne unit, 




Beckwith and co-workers153 have made use of an alkoxycarbonyl radical,
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generated in a similar fashion, which undergoes an intramolecular ring-closure 
onto a nearby alkene bond, rather than an alkyne. The result is a comparable 
lactonisation process, though it occurs via the formation of a different 
carbon-carbon bond. We believe this reaction, by Beckwith and co-workers, to be 
the only example of the use of alkoxycarbonyl radicals to generate lactones such 
as (150). Such a reaction has not been performed using acetylenes, but there 
seems little reason to doubt that this should be equally successful.
Therefore, the imidazolylalkyne (151) became our first key intermediate, see 
scheme 31. This compound should be available from the alkylation of
Ph




ethyl-2-bromobutanoate by the alkyne (152), as shown in Scheme 18 of Section 
1-9. The (R)~ and (S)-bromobutyric acids (123) and (124), indicated there, have 
already been prepared in optically pure form, from natural amino acids, by 
Rapoport and Compagnone.89
An unsuccessful synthesis of the alkyne (152) was first reported in 1972 by 
Shvartsberg et. a /.,154 in which they describe the product as a mixture of the 










disubstituted compounds (154) and (155), as well as triacetylenylimidazole (153). 
The problem with this reaction was that the initial halogenated imidazole was 
actually a mixture of various mono- and dihaloimidazoles; hence the variety of 















No further report of 5-ethynylimidazoles appears until several years later,155
55












lead to a homogeneous product however, probably because the starting iodo 
compound (156) was contaminated with other isomers.
Given the lack of a suitable preparation for the alkyne (152), we set out to 
develop our own synthesis - which would be specific for the single isomer we 
required. It seemed likely that access to the acetylene (152) could be gained from 
the known152,156,157 aldehyde (55): by either a Corey-Fuchs methinylation,158 or 
via a Wittig reaction with the bromomethylenetriphenylphosphorane (159). In the 
later case, a bromoalkene (160) would be formed which could then be 
dehyrobrominated.159
3.2 Synthesis of l-methyl-5-formylimidazole (55).
l-Methyl-5-formylimidazole (55) was first prepared by Hubbal and Pyman,157 
but in poor yield. Jones and Mclaughlin used a modified method, making first the 
ester152 (54) which they subsequently converted into the aldehyde (55).156 Their 











Br (152) (120) 
X = C1NMe
(160)
proceeds via N-substituted glycine derivatives to give 1,5-disubstituted 
imidazoles, as shown in Scheme 32. Our initial approach142 to the aldehyde (55) 
was a repetition of Jones and Mclaughlin’s preparation.
Formation of the N-formyl glycine ester (163) was achieved cleanly, but the yield 
was disappointingly low - mostly as a result of problems we encountered in 
purification of the hydrochloride (162). This difficulty was caused by removal of 
the ammonium chloride formed during solvolysis of the nitrile function in the 
formation of the ester (162). We found no suitable method for separating this salt, 
other than distillation of the formamide (163). This was only partially successful, 
presumably due to sublimation of the ammonium chloride.
Enolisation of ester (163) proceeded smoothly, and was followed by a reaction 
with methyl formate to give the homologated enolate (164). However, 
nucleophilic attack upon the corresponding aldehyde by potassium thiocyanate, 
which we had expected to be followed by cyclisation to give
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2-mercaptoimidazole (165), was unsuccessful. The reason for this is not clear, but 
all our subsequent attempts to obtain this product also failed.
We were also unhappy with this route for several other reasons; it consists of a 
large number of steps, many of which are low yielding, and it involves a 
large-scale reaction with potassium cyanide. We therefore sought an alternative 
approach, and noted the applicability of an imidazole synthesis developed by van 
Leusen et. a / .160,161 which involves the use of toluenesulphonylmethyl isocyanide 
(TosMIC). These authors had demonstrated that 5-monosubstituted imidazoles 
are accessible using this reagent, and thus we hoped to extend that method to the 
synthesis of l-methyl-5-ethynylimidazole (151).
Initially, we believed it pmdent to repeat a known synthesis using TosMIC in 
order to verify that we could reproduce the necessary conditions - which are
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critical for success. We chose, as an example, a reaction between TosMIC and 
benzaldehyde which finally produces 5-phenylimidazole (174). The mechanism 




















The formation of imidazoles occurs by a three-step process: the first of these 
proceeds via the 4-toluenesulphonyl-2-oxazoline species (168), which ring-opens 
to afford the corresponding /V-(l-toluenesulphonyl-l-alkenyl)formamide (170). 
The reason for the criticality of the reaction conditions is the possibility of 
p-elimination of p-toluenesulphinic acid, which leads to the formation of 
oxazoles. Such a reaction can dominate at higher temperatures and provides an 
entry into the oxazole ring system. A further example of the adaptability of the 
TosMIC reagents, is their use in the synthesis of pyrroles where they react with a 






The next step in the formation of the imidazole (174) from the
N-( 1 -toluenesulphonyl-1 -alkenyl)formamide (170), is dehydration with
phosphoms oxychloride which produces the a-p-unsaturated sulphonylisocyanide
(173). The last reaction stage in the formation of l-methyl-5-phenylimidazole
(174) commences with a Michael-type addition of methylamine to the isocyanide
(173), followed by ring-closure. Subsequent p-elimination of p-toluenesulphinic 

















In our hands this synthesis worked well, and so we felt confident about applying 
the methodology to our synthesis of alkyne (152); thus we reacted TosMIC with 





Our final, successful, approach to the acetylene (152) again involved the 
aldehyde (55). We discovered a route to the aldehyde (55), starting from
1,2-diaminomaleonitrile, which was based on a literature synthesis, by Rapoport 
and co-workers,162 of methyl ester (54). Having succeeded in preparing that 
compound, we reduced it to the aldehyde (55) using the method of Jones and 
Mclaughlin.156 All the yields were good, except for the last one (Scheme 35).
Formation of 4,5-dicyanoimidazole, from the dinitrile (175) and 
triethylorthoformate, involved distillation of ethanol from the reaction mixture. 
This has the effect of displacing the equilibrium position in favour of an 
intermediate product which still contains an ethoxy substituent. This compound 
must be treated with sodium methoxide in order to obtain the dicyanoimidazole 
(176) in 90% overall yield. Selective N-methylation of asymmetric imidazoles is 
generally a complicated process;87 however compound (176) is symmetrical and 
so methylation affords the mono-methylimidazole (177) as the sole product, in 
60-65% yield.
Hydrolysis of the dinitrile (177), by refluxing in potassium hydroxide, gave a 
99% yield of a yellow solid, which is the dicarboxylic acid (178). Selective 
mono-decarboxylation occurs when this is heated in acetic anhydride solvent, and
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the product is almost exclusively l-methyl-5-imidazole carboxylic acid 
(179)(95%) with only a 5% yield of 1 -methylimidazole-4-carboxylic acid. It is 
reported by Takahashi and Mitsuhashi163 that when the reaction is attempted 
using N//-dimethylacetamide as solvent, decarboxylation occurs predominantly 
at C-5 giving a 75% yield of the 4-carboxylic acid.
Cohen and co-workers130 have carried out extensive ^  nm.r. studies of the 
deprotonation-reprotonation of 1-methylimidazole. They discovered an almost 
exclusive preference for anion formation at C-5, at temperatures above 100 °C, 
and suggested this effect was due to electrostatic repulsion between the anion
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formed at C-4 and the sp2 lone pair on the adjacent nitrogen atom, so 
disfavouring this anion, as shown in intermediate (182). In the case of anion 
formation at C-5, these two electron orbitals are non-adjacent and so that anion 
(183) is not as disfavoured.
(182)
NMe
Takahashi and Mitsuhashi believe similar considerations apply to the 
decarboxylation reaction of the acid (178), in non-electrophilic solvents such as 
N//-dimethylacetamide, leading to the 4-carboxyimidazole (187) as the major 
product. However, in acetic anhydride the possibility of acetylation of the
- C02, - H+
\ — NMe V  " r— NMe









sp2-hybridised nitrogen atom has the effect of removing that atom’s lone pair,




















Interestingly the temperature of the reaction also appears to be important; we 
observed that heating the reaction to 140 °C, rather than at 100 °C, for four hours, 
led to the formation of a black tar which could not be characterised. Other 
workers164 have shown that prolonged heating of diacid (188), in boiling acetic 
anhydride, leads to the formation of diimidazo[3,4-a;3\4’-<i]piperaz in-2,5-dione









Throughout this series, the chemical shift values of the H-2 and H-4 proton
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resonances tend to be very close. Spin-spin coupling can be observed; between 
H-2 and H-4, or H-2 and H-5, respectively. These interactions have distinctive 
coupling constants.165 In aprotic solvents, such as DMSO-D6, J2 4 is typically 
smaller than J2 5. The former has values ranging from 0-9 to 1 0 Hz, and the latter 
is in the range from 1 • 1 to 1 -5 Hz. The value we observed for both the acid (179) 
and the subsequent ester (54) was J = 0*94 Hz, indicating coupling between H-2 
and H-4. In CDCI3 solvent, all coupling was lost and a broad peak for each of the 
aromatic protons was seen.
An interesting point, which was observed during the course of this work, is the 
resonance of H-2 for the diacid (178) in DMSO-D6 appears at 8 9* 1 - not at the 
expected value of 7-6, though other data confirmed the structure assigned. In the 
spectrum of the mono decarboxylated product, the signal in question was again 
observed at 5 7-6. The reason for this is not clear, but we suggest that the 
electron-withdrawing effect of the second acid function may be sufficient to 
increase the lability of H-2 enough for it to undergo exchange with the carboxylic 
acid protons.
The acid (179) was subsequently treated with thionyl chloride, in dry methanol, 
and distillation of the resultant brown oil produced the methyl ester (54), as a 
colourless crystalline solid, in 56% yield. Nucleophilic displacement of the 
methoxy group, by treatment with hydrazine hydrate at 40-60 °C, gave the 
hydrazide (180) in 90% yield. This compound was stiired with benzenesulphonyl 
chloride, using pyridine as base, affording benzenesulphonylhydrazide (181). 
Treatment of compound (181) with sodium carbonate, in glycerol at 170 °C, 
resulted in the evolution of nitrogen gas from the reaction mixture and production 










It is thought that sodium carbonate abstracts a proton from glycerol, and the
resulting alkoxide is the actual base which deprotonates the nitrogen atom a- to
o<
the carbonyl group. Elimination of the benzenesulpfrinyl group, followed by 
liberation of nitrogen, results in the production of l-methyl-5-formylimidazole 
(55).
At this point, we noticed a recent publication by Katritzky and co-workers166 in 
which they claim a one-pot synthesis of monoacid (179) directly from
1-methylimidazole. These authors state that 1-methylimidazole can be converted 
to acid (179) by treatment with two equivalents of a "butyl 
lithium-tetramethylethylenediamine complex and dry carbon dioxide. The 
intermediate 2,5-dicarboxylic acid is said to undergo C-2 decarboxylation166 to 
give monoacid (179), as shown.
The attraction of such a facile synthesis is obvious; but we were unable to repeat 
the preparation, obtaining instead a complex mixture which could not be fully 
characterised. None of the monocarboxylic acid (179) was isolated. Furthermore,
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there are anomalies in the data quoted by Katritzky and co-workers.166 It seems 
strange that an aqueous work-up should be used, as our experience with this 
compound has shown it to be extremely water-soluble.
We were puzzled by the claims of these authors to have observed a mass peak of 
154 in the 70 eV mass spectrum of the monoacid (179). The highest peak to be 
found in our mass spectrum of the same compound, formula C5H6N20 2 , was the 
calculated value of 126. Katrizky and co-workers also indicate the presence of a 
resonance at 6 8-80, assigned to the acidic proton, in their n.m.r. spectrum of 
the acid (179) - for which no solvent was quoted. We do not see such a signal in 
our :H n.m.r. spectrum. Although our data otherwise agrees with that of 
Katritzky’s group, their 13C n.m.r. chemical shift figures differed from ours by 
between 0*5 and 5 p.p.m.
We believe the data quoted by Katritzky is more consistent with the acetamide
(190). This compound has formula CgHgN20 3 and molecular weight 154, and we 
feel it possible that intramolecular hydrogen bonding accounts for the presence of 
the acidic proton resonance, as well as the apparently reduced water solubility of 
their product. Since ethyl formate is added to the reaction mixture, presumably to
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assist the decarboxylation at C-2, we feel the acetamide (190) may have arisen as 
shown below.
0 2C\ r o 2c x  . / ^ O  R 02C\ ^  y )






We made another attempt to optimise our synthesis of the aldehyde (55) from the 
acid (179). This compound was reacted with 9-borabicyclo[3.3.1]nonane167 and 








9BBN = 9-Borabicyclo[3.3.1]nonane (54)
°C produced a black material, which on purification gave a brown oil. This 
proved to be a complex mixture, but a small trace (less than 2%) of the aldehyde 
(55) was present along with unreacted acid (179). It was concluded that 'butyl
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lithium had removed the C-2 proton and the borane complex had only partially 
formed. Disappointed with this result, we returned to our original synthesis of the 
aldehyde with no further attempts at optimisation.
3-3. Investigation of Wittig and Corey-Fuchs reactions aimed at the 
synthesis of 5-ethynyI-l-methyIimidizoIe (152).
Rapoport had reported89 that Wittig reactions between certain reagents and the 
aldehyde (55) could present problems. Therefore we started by performing a 
simple Wittig reaction between the aldehyde (55) and
methyltriphenylphosphonium bromide, using the general procedure of Still.168 
This reaction proceeded smoothly to give alkenylimidazole169 (191)(90%). The 
*H n.m.r spectrum contained signals for the resonances of the alkeneic protons at 
8 6-50,8 5-58, and 5 5-22.
Satisfied that a Wittig reaction would occur with aldehyde (55), we chose to use 
the Corey-Fuchs158,170 reaction in our first attempt to synthesise the acetylene 
(152). Simply stirring carbon tetrabromide, triphenylphosphine and a catalytic 
amount of zinc, at room temperature over the course of 48 hours, produced a 
plum-coloured solution containing dibromotriphenylphosphonium ylide.





producing a brown solution. Unfortunately, analysis by t.l.c. showed that only 
starting material was present. Repetitions of the reaction, but with stirring for 
different time intervals, between 24 and 168 hours at room temperature, had no 
effect and starting material was recovered each time. It seems likely that the ylide 
simply behaves as a base,171 and removes a proton from C-2 of the imidazole, 




2 eq. CBr4, /  NMe
--------------- ------- -ft* -  Br / /  '\2 eq. Ph3P, Zn "  N
(158)
An alternative explanation is that the oxaphosphetane is formed, but fragments 
giving a retro-Wittig reaction to starting material. This phenomenon has been 
observed on a number of occasions172,173 and appears to be dependent on the 
structure of the oxaphosphetane intermediate, and on the reaction conditions. 
Since the dihaloalkene (158) could not be prepared by this route, we turned our 
attention to formation of the monohaloalkene (192) - from which 
dehydrohalogenation should give the desired acetylene (152).
Several examples of 1-haloalkene syntheses exist in the literature, most of which 
rely on halomethylenetriphenylphosphoranes174 and strong base. However, one 
route175 starts with the corresponding alkyne which is treated with CHX2BH to 
generate a vinylborane. On treatment with acid this species generates the
1-haloalkene.
The most general of these routes appears to be the method of Stork,174a which we 
successfully applied to the synthesis of the iodoalkene (192) in 98% yield.
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Previously we had tried the method of Seyferth,174c but the use of ”butyl lithium 
had led to metal-halogen exchange with (iodomethylene)triphenylphosphonium 
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The required phosphonium salt was prepared by heating triphenylphosphine with 
methylene iodide at 45 °C for 4 hours. The best yields of the iodoalkene isomers
(192) and (193) resulted from using sodium hexamethyldisilazane as base. It has 
been shown that the stereoselectivity of the iodo-olefin formed in reactions such 
as this depends on the temperature. At -78 °C, with an unstabilised ylide, a high 
proportion of the Z-alkene isomer is recovered. In our case a 40:60 mixture of 
E:Z isomers was obtained, the XH n.m.r. spectrum of which showed the olefinic 
proton resonances of the two isomers with spin-spin coupling constants of 9 and 
15 Hz respectively.
The Z isomer predominates as the ylide used in this reaction is unstabilised.176 In 
this case the kinetically preferred erythro betaine collapses irreversibly to give 
the Z-alkene. When a stabilised ylide is the reagent the erythro betaine is in 
equilibrium with the more stable threo form, which leads in turn to the 
thermodynamically preferred alkene (see Scheme 37).
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with two equivalents of "butyl lithium, leading to dehydrohalogenation. T.l.c. 
analysis indicated that two products were produced; the less polar component 
was very volatile, and proved to be the desired alkyne (152), whilst the more 
polar compound was the vinylimidazole (191). Unfortunately the latter
H
NCHNCH3 2 eq. "BuLi,I NCH
+
compound predominated in a 3:2 molar ratio. A large excess of base did nothing 
to improve this ratio in favour of the alkyne. It was thought that metal-halogen 
exchange also occurred during the reaction affording the vinyl anion which on 
work-up simply gave the alkene (191).
During the purification of the alkyne (152), the compound was found to have a 





flushes, faintness, numbness, spasms and stiffness in the muscles of the stomach 
and legs, difficulty in breathing, and a sensation of extreme intoxication. Some of 
these effects manifested themselves only gradually, taking up to several hours to 
appear. It is possible that alkyne (152) may behave as a muscarinic agonist, since 
decreased blood pressure was diagnosed. The structural requirements for a 
muscarinic agonist64 are all fulfilled by the alkyne; namely, it possesses a tertiary 
nitrogen centre, and an electron-rich side chain.
Only miligramme quantities of the alkyne were enough to cause this effect, even 
as small as the loading on a t.l.c. plate. Possibly the volatility of this compound 
contributes to this problem. The C-silyl derivative had an even greater effect on 
both the author and a colleague. Sensitisation of the author to the compound was 
demonstrated by the fact that each exposure led to a more drastic response. It is 
noted that the author’s supervisor and a second colleague did not exhibit the 
symptoms after handling the alkyne (152).
Because of these difficulties, the alkyne (152) was never completely purified, but 
sufficient data were obtained (see Experimental) to confirm its structure. Because 
of the sensitivity of the author to alkynylimidazoles, all further work in this area 
was performed by other workers. An attempt was made by the author’s 
supervisor to convert the iodoalkene into its lithio-derivative, and to react this 
with ethyl 2-bromobutyrate. Only one product was observed by t.l.c. analysis
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which later proved to be the diethyl succinate derivative (195) produced from a 




No imidazole containing product was isolated, although it must be acknowledged 
that the material balance of the reaction was poor.
An undergraduate project student177 showed that treatment of the iodoalkene 
(193) with three equivalents of ”butyl lithium, and two equivalents of 
'butyldimethylsilyl chloride, led to the production of two major products. These 
were identified as the C2-silylated alkene (196) and the disilylated alkyne (197).






unfortunately the disilyl compound was not easy to handle. It was volatile and 
potentially toxic; as a result it was treated with great caution and only a mass 
spectrum was recorded. This showed a molecular ion peak at mlz 338.
Having shown, albeit tentatively, that alkylation of alkyne (152) with
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'butyldimethylsilyl chloride was possible, we applied the same conditions to a 
subsequent reaction. This time the alkylation was attempted using a 5% solution 
of ethyl 2-bromobutyrate, since we hoped that using a dilute solution of the 
bromoester would prevent dimerisation. However, no alkylated product was 
isolated and only the vinylimidazole (196) was obtained. A possible explanation 
for this result stems from the observation that only primary alkyl halides178,179 
unbranched at the (J-position give good yields on alkylation with acetylenes.
It has been reported180 that silyl acetylenes react with tertiary halides, in the
presence of a Lewis acid catalyst, giving tertiary alkyl-substituted alkynes. This
reaction results from the facile fission of the C-Si bond in the presence of halide
ions. Since we believed we had prepared the disilylacetylenylimidazole (197), we
hoped we could apply such a reaction to our synthesis of pilocarpine. The
*
mechanism of this reaction is thought180 to involve a carbjhnium ion, generated 
from alkyl halides by a Lewis acid. It is suggested that this species reacts with a 
silylacetylene to give a vinyl cation, which undergoes elimination of the silyl 
group and forms an alkylated alkyne (Scheme 38).
Airn /SiM e3  A1C13, +___/  3
R  =  SiMe3 ---------------- ► R---- ----- (  + A1C14'
‘BuCl
alkynide
---------------► R =  *Bu + Me3SiCl
+ A1C13
Scheme 38.
This reaction has so far not been successful when applied to primary and 
secondary alkyl halides. However we thought it was sufficiently promising to be
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worthy of investigation. We repeated the reaction of the iodoalkenylimidazole
(193) with "butyl lithium and 'butyldimethylsilyl chloride to generate 
disilylalkynylimidazole (197), then added aluminium trichloride, followed by the 
racemic bromoester (194). However, the desired reaction failed and the XH n.m.r. 
spectrum indicated 2-T>utyldimethylsilyl-5-ethenyl- 1-methylimidazole (196) to 
be the major product. None of the bromoester starting material was isolated, nor 












After the failure of our earlier work, we wished to investigate if such difficulties 
characterise the alkylation reactions of simpler aromatic acetylenes. Thus we 
reacted phenylacetylene dissolved in THF with "butyl lithium at -78 °C, to form 
an anion. When the reaction mixture was allowed to warm above -78 °C, a white 
precipitate separated. Earlier reports181 have shown that lithioacetylene 
compounds are very sensitive to temperature. A temperature rise of just 10 °C 
produces a precipitate which will not redissolve whether, or not, the temperature 
is depressed again.
In our experiment a constant temperature of -78 °C was maintained, but the
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addition of ethyl 2-bromobutyrate produced a black solution. Analysis of this by 
t.l.c. indicated the formation of a single product, but also showed that a 
considerable amount of starting material remained. An attempt to purify the 
product by chromatography over silica gel resulted in uncharacterisable materials 
- indicating decomposition on the silica.
Repeating the experiment, this time using a Kugelrohr apparatus to distill out the 
product, led to the recovery of bromoester starting material - but no 
phenylacetylene and none of the desired product. We cannot explain the 
disappearance of the starting alkyne, and base-mediated dehalogenation of the
"BuLi,








bromoester does not appear to occur.
A final attempt at generation of the acetylene anion was made, using an 
equimolar quantity of a mixture of "butyl lithium182 and potassium 'butoxide 
(2:1) in tetrahydrofuran-hexane at -78 °C. This time, only unreacted bromoester 
and phenylacetylene were recovered. We now sought to use a more reactive 
nucleophile in order to achieve coupling of the lactone and imidazole halves of 
pilocarpine.
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3-4. Attempted access to the pilocarpine skeleton via Michael addition of 
5-dithianylimidizole to 2(5H)furanone.
3-4*1. Introduction.
Thioacetals are versatile reagents, allowing reactions183 such as nucleophilic 
attack of the 5,5-acetal unit on an electrophilic species; a reaction which would 
not be possible using carbonyl compounds directly (an Umpolung process).
The high stability of the 1,3-dithiane function, towards elevated temperatures, 
acids, bases, and during the course of chromatography, makes the use of
2-lithio-l,3-dithianes especially appropriate early in a multistep synthesis. A 
comprehensive review of thioacetal chemistry has been published by Gobel and 
Seebach.184
Given the facile lithiation of 1,3-dithianes, many nucleophilic reactions are 
possible, but our attention was drawn to the conjugate addition of dithianes to 
a,p-unsaturated aldehydes, ketones, and cyclic esters. It has been shown that 
metallated thioacetals demonstrate a high preference for non-conjugate
1,2-addition to a,p-unsaturated carbonyl compounds,185 and Stork argued that, in 
the case of a lithiated thioacetal, coordination of the metal with the oxygen atom 
of the Michael acceptor may be important.
However, it has recently come to light that smooth 1,4-addition of a lithiodithiane 
to an enone can sometimes occur; this appears to be related to the intrinsic 
stability of the dithiane anion.186*188 We were particularly intrigued by recent 
work concerning the production of lignanic lactones using this approach.189,190 
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Michael addition. Our retrosynthetic plan is shown in Scheme 39, the key step 
involving 1,4-addition of 5-(1,3-dithian-2-yl)-1-methylimidazole to 
2(5H)-furanone, followed by quenching of the resultant anion with ethyl iodide. 











3-4-2. Preparation and some nucleophilic reactions of 
5-(l,3-dithian-2-yI)-l-methylimidazole.
Formation of the dithiane (205) proceeded smoothly, using the procedure of 
Marshall and Belletire.191 To ensure complete reaction, 2-5 equivalents of borane 
trifluoride etherate was required. Removal of the solvent left a colourless solid 
which proved to be the boron salt (206) of the required compound. Subsequent 
treatment with 2M sodium hydroxide, at room temperature, liberated free 







Formation of the borane salt caused a large difference in the chemical shift of the 
imidazole proton resonances in the *H n.m.r. spectrum; that due to 2-H appeared 
at 5 9-07, as opposed to 8 7-38 in the parent molecule. The *H n.m.r. signals 
corresponding to the methylene protons at C-5’ exhibit geminal coupling, as well 
as a difference in chemical shift, with one multiplet at 5 1 - 85 and another at 5
2-07. This is because they are now diastereotopic, such that one of the protons 
maintains a cis- relationship to the imidazolyl unit, whilst the other is trans- to it. 
We envisaged a problem in generating the lithiodithiane due to the higher acidity 




therefore carried out a deuteration and methylation study, in order to verify our 
assumption. We treated the molecule with one equivalent of "butyl lithium, and 
quenched the mixture with D20 . Indeed, we found the intensity of the signal of 
the 2-H proton, at 5 7*3, was substantially reduced - as opposed to the signal 
corresponding to the 2-proton of the dithiane unit which remained unchanged. 
Encouraged, we proceeded to treat the thioacetal with two equivalents of "butyl 
lithium, followed by three equivalents of methyl iodide. The resultant compound 
(207) exhibited a *H n.m.r. spectrum containing three methyl group signals. We 
were confident, from the physical data, that initial methylation of C-2 had been 
followed by lithiation and methylation of the thioacetal unit, as we had hoped 
(Scheme 40).
We now required, once again, to achieve selective protection of the imidazole 
C-2 position - in order to allow an unhindered reaction between the lithiated 
thioacetal group and 2(5H)furanone. Having achieved good results using 
'butyldimethylsilyl as a protecting group, this was again selected. Silylation of 
imidazole (205) was achieved readily, giving a 90% yield of
l-methyl-2-/butyldimethylsilyl-5-(l,3-dithian-2-yl)imidazole (210) (Scheme 41).
Treatment of silyldithianylimidazole (210) with an equivalent of "butyl lithium 
led to the formation of a deep orange solution, as we had observed in our earlier
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Scheme 41.
fomiation of other lithiated dithianes. Freshly distilled 2(5H)fiiranone was added 
to the reaction mixture, after which the intense colour gradually faded. Analysis 
of the mixture indicated a number of products had formed, but starting materials 
predominated. The reaction mixture was allowed to warm to room temperature, 
ethyl iodide was added, and the mixture was extracted; however only starting
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material was recovered. Too little of the minor components were present to allow 
their identification. We subsequently repeated the reaction several times, varying 
the conditions: temperatures in the range -20 °C to -80 °C were employed, and 
copper (I) iodide was introduced in an attempt to produce the corresponding 
cuprate. All of these modifications had no significant effect on the outcome, and 
at no time could any trace of the 1,2- addition adduct be detected. A modified 
work-up was employed, using 2M hydrochloric acid, but this merely resulted in 
desilylation of the starting imidazole.
Lithiation at C-2 of the dithiane unit was not in doubt from the earlier deuteration 
and methylation studies. We therefore believed that the lithiodithiane behaves as 
a base, rather than as a nucleophile, leading to deprotonation of 2(5H)furanone, 
and subsequent recovery of starting material on work-up (Scheme 42).






In preceding cases where aryldithianyl anions undergo Michael addition to
2-(5H)furanone an activated aromatic system has been present in the nucleophile.
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For example,189b apara-benzyloxy electron-releasing substituent acted to 
increase the electron density at the anionic centre and improve the nucleophilic 








conjugated to the aromatic ring, and the reactivity of the anion (211) may even be 
reduced by delocalisation of the charge into the ring.
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CHAPTER 4
4. LATE LACTONISATION INVOLVING ATTEMPTED ALKENE 
FORMATION, AND ITS SUBSEQUENT ELABORATION, FROM
l-METHYL-5-FORMYLIMIDAZOLE VIA A WITTIG REACTION.
4-1 Introduction.
We now sought to apply the lessons we had learned from our previous 
experiments. We still favoured the strategy based upon a radical induced 
lactonisation, which was proposed in section 3-1, but which had foundered due 




cyclisations of radical species onto alkenes, affording lactones, are also well 
known.192,193 We wished to investigate this strategy using selenide (214), which 
would be available by the methods of Beckwith194 and Pigou,153 in the 
lactonisation step as shown in Scheme 43.
We believed that the alkene (214) would be accessible through established 
methodology such as the Wittig reaction, but we were aware of the possibility of 
double bond migration into conjugation with the ester group. However, such an 
isomerisation would lead to the alkene (213), which may also be a suitable 











The lactone (14), obtained from cyclisation of either alkene (213) or (214), would 
lack the exocyclic double bond arising from reaction of the corresponding alkyne. 
There would also be no preference in the absolute stereochemistry of the lactone 
substituents, since precursors (213) and (214) are achiral. Furthermore, the 
relative stereochemistry of these groups would be determined by the outcome of 
the cyclisation; we could not induce a cis- relationship by alkene reduction, as 
proposed in Chapter 1.
Unfortunately, literature examples192,193 indicate that the fra/u-cyclisation 
product predominates in such processes - especially for acyclic precursors.193 
There are known examples of such cyclisations giving cis- ring-fused products, 
but not in the sense we require. In such cases, the bond which is cis- is that which 
is common to both rings; however the example192 in Scheme 44 illustrates that 
the stereochemistry about the new bond is almost invariably trans-, presumably
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due to steric factors. In the cyclisation we propose, of selenide (213) or (214), 
steric repulsion between the ethyl and imidazolylmethyl groups would probably 
lead to the trans-product. Such a synthesis would produce, predominantly, 
racemic isopilocaipine; requiring resolution and epimerisation. However, this 
was also the case in Rapoport’s synthesis, and we judged that a short and 
efficient procedure would justify such a necessity.
4-2 Application of the Wittig Chemistry to the formation of
5-(3-carboxyethyIpent-l-enyl)-l-methyIimidazole (216).
The synthesis of alkene (214) was undertaken using the reactions oudined in 
Scheme 45. The starting material was ethyl butanoate which was C-formylated 
by the procedure of Klioze and Daimary,195 using lithium di-isopropylamide and 
ethyl formate, to yield the aldehydic ester (219). Reduction with sodium 
borohydride afforded the alcohol (220), however bromination of this compound 
with triphenylphosphine and carbon tetrabromide196-199 failed. Recourse to 
phosphorus tribromide200 in pyridine was successful, and the bromoester (221) 















Our first choice of starting material, ethyl butanoate, was occasioned by its 
cheapness and availability; but dictated ester hydrolysis in order to form the 
selenide (214). We recognised that deprotection of the ester (216) would probably 
isomerise the double bond into conjugation with the carboxyl group. This would 
afford us with target molecule (213), but would defeat our access to isomer (214). 
Consequently, we attempted to mask the carboxylate function as the 
1,3-oxazolinyl derivative (223). The merits of this protecting group are its 
relative inertness to reducing conditions,201 and facile removal under acidic 
conditions202 that are far milder than those required for ethyl ester hydrolysis; 






























Hydrolysis of the hydroxyester (220) with 2M sodium hydroxide solution 
afforded the hydroxy acid (222), but, disappointingly, its reaction with
2-amino-2-methylpropanol203 failed. A red-orange gum was obtained, which was 
insoluble in most solvents. We could have protected the primary alcohol prior to
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reaction with the aminopropanol, but we decided that investigation of the key 
Wittig olefination reaction had a higher priority.
Phosphonium salt (215) was prepared by reaction between bromoester (221) and 
triphenylphosphine. Rather than use the imidazolylaldehyde (55), we utilised 
benzaldehyde as a model substrate and reacted it with the ylide of the 
phosphonium salt (215) (formed in situ by the addition of "butyl lithium). This 






n.m.r. spectrum exhibited signals due to five aromatic proton resonances and 
those of an ethoxy carbonyl group. However, only one alkenic signal was present, 
as a triplet ( /  = 8 Hz) at 5 5-60, indicating that spin-spin coupling occurs between 
this resonance and that of an adjacent methylene group. This evidence that, as we 
had predicted, isomerisation of the double bond had occurred under the basic 
reaction conditions; leading to the a,p- unsaturated ester (224), rather than its 








synthesis of the target molecule (213), the yield in the Wittig reaction was most 
discouraging.
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An alternative, olefination of the phosphonium salt (226) was performed, in an 
attempt to achieve a workable yield. The expected product (227) could then be 
hydrolysed and decarboxylated.













Surprisingly, all attempts to C-formylate diethyl ethyl malonate failed, perhaps 
because the electrophile ethyl formate is insufficiently reactive to combine with 
the enolate anion (228). However, vigorous effervescence was observed on 
addition of ethyl formate, which was consumed during the reaction, and the 
formylating agent triethylorthoformate also failed to react with the enolate anion. 
Therefore, it seems more likely that the desired reaction occurs; but elimination 
of the stabilised anion (228) follows, liberating carbon monoxide and 
regenerating the starting diester. We noted that the literature2034 indicates very 
forcing conditions are often required to alkylate diethyl malonate.
CHO
Et02CH
Et02C C 02Et 
(228)
it Et02C C 02Et 
(229)
As with all model reactions which fail, we were overcome by temptation to
91
repeat the procedure with the actual substrates we had planned - in order to verify 
the applicability of the model results. Thus, a Wittig reaction was undertaken 
between 5-formyl- 1 -methylimidazole and the phosphorane formed from salt 
(215); however this failed completely, and only the starting aldehyde was 
recovered. It is possible that the electron-releasing effect of the imidazole ring 
lowers the electrophilicity of the aldehyde. It is also known204,205 that the 
negative charge of phosphoranes can be delocalised into the d-orbitals of the 
phosphoms atom, reducing the reactivity of the ylide.
These disappointing results brought this line of enquiry to a close. Our experience 
did not convince us that clear-cut and facile Wittig-type reactivity was feasible 
for the aldehyde (55), or that this approach was worthy of more effort, and so we 
chose to look at other methodologies.
4-3 Formation of l-MethyI-5-oxiranyIimidazoIe.
4 -31  Introduction to some epoxide chemistry.
Epoxides represent very useful synthetic tools in natural product synthesis 206 
This is particularly true of the diastereomerically pure products obtained from 
application of Sharpless epoxidation207 conditions to allylic alcohols. Extensive 
reviews208 of this reaction have been published.
As well as direct epoxidation of alkenes,209 epoxides are commonly formed from 
aldehydes using dimethyloxosulphonium methylide - otherwise known as 
Corey’s ylide 210 The known compound 3-oxiranylpyridine (231) is reported211 to 
be very unstable, readily undergoing ring-opening at the less sterically hindered 
end to form the corresponding diol. Syntheses of 3-oxiranylpyridine (231) use 
either the appropriate aldehyde (230) or the olefin (232) (Scheme 47).
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NBS = N-bromosuccin amide
TEBA = benzyltriethylammonium chloride
Scheme 47.
The analogous 5-oxiranyl-l-methylimidazole (233) is a novel compound. 
Nevertheless, we expected it to behave in a similar fashion to compound (231), 
thereby presenting a key intermediate in a possible synthesis of pilocarpine. We 
aimed to generate this species and ring-open it in situ, with the enolate anion of 
ethyl propionate, to give the alcohol (234). Dehydration to form an alkene, for 
subsequent ring-closure via a selenide, would give a mixture of (±)-pilocaipine 
and its isomer, see Scheme 48.
The route as it stands is not asymmetric, and any attempt at a chiral preparation 
of the epoxide (233) would be rendered valueless by the subsequent dehydration 
step. Nonetheless alkene (235) does look an attractive intermediate, due to its 
potential for synthetic flexibility. Standard methodology might allow its 
manipulation to form cyclisation candidates such as alkyne (236) (or its 
equivalent allene (237)), and the diene (238). Successful radical lactonisation 
would afford a dehydropilocaipine, whose hydrogenation would again introduce 














AIBN = azobisbutyronitrile 




4-3-2. Epoxidation and subsequent ring-opening of
l-methyI-5-formylimidazole (55) and 5-ethenyl-l-methyIimidazole (191). 
Having available a ready supply of both aldehyde (55) and alkene (191), we were 
able to perform a variety of manipulations. Mera-chloroperbenzoic acid212 has 
often been used successfully to generate epoxides from alkenes. As the 
conditions employed are relatively mild, this reagent was our first choice. 
However, on treatment of alkene (191) with meta-chloroperbenzoic acid, a white 
precipitate immediately began to form. After stirring the reaction mixture for 24 
hours, no starting material was observed by t.l.c. analysis; but on work-up of the 








mera-chloroperbenzoic acid is sufficiently acidic to protonate the tertiary nitrogen 
lone pair of imidazole (191). This would lead to precipitation of the imidazole 








mCPBA = meta-chloroperbenzoic acid 
Scheme 49.
We next turned our attention to the aldehyde (55) and the use of Corey’s ylide.
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The dimethyloxosulphonium methylide is very nucleophilic and serves to transfer 
methylene groups to electophilic substituents such as aldehydes and ketones. This 
reaction is generally carried out by treating the aldehyde with sodium hydride and 
the sulphoxonium salt in dimethylsulphoxide solvent. In practice we observed 
that such a reaction of the aldehyde (55) led to rapid liberation of hydrogen, and 
after 2 to 3 hours all starting material had disappeared.
Only one product was isolated, and surprisingly this proved to be the 
sulphoxyalkene (239). When the experiment was repeated using only 
dimethylsulphoxide and sodium hydride as reagents, the same product was 








(55)  ► (239)
deprotonation of the sulphonoxonium salt, and the resultant anion of 
dimethylsulphoxide attacks the carbonyl preferentially. Once this happens, the 
sulphone group facilitates deprotonation at the a-proton, and hence dehydration 
to give the alkene (239), as shown in Scheme 50. Interestingly, there appears to 
be no report of this type of side reaction occurring during reactions with Corey’s 
ylide.
The yields for these reactions were poor (20%), but this can be attributed to loss 
of the water-soluble product during the work-up procedure. Prolonged reaction 








hours simply decomposed the starting material. It seems likely that both the ylide 
and the anion are formed under the reaction conditions, but that the ylide benefits 
from resonance stabilisation. Therefore, the unstabilised anion is more reactive 
towards the aldehyde, dictating the product and excluding the desired reaction 
between ylide and aldehyde.
Although an interesting outcome, this result did not help us in our synthetic aims, 
and so we returned to alkene (191) and its epoxidation. Sharpless213 epoxidising 
conditions were chosen, using vanadyl acetylacetonate as catalyst. The reaction 
proceeded as stated for literature examples, culminating in the production of a 
single compound as shown by t.l.c. analysis. An aqueous wash and subsequent 
extraction with ethyl acetate afforded a brown oil, containing only a trace of the 
alkene (191). However, the aqueous phase was intensely u.v. active, and we 
assumed it to contain the diol (240) or a related derivative.
This compound could not be characterised, as it affected the author severely. 












breathlessness and giddiness. These symptoms, experienced by the author and 
one of her colleagues, were similar to those detailed in Chapter 3. An attempt was 
made to freeze dry and extract the aqueous phase but, again, alarming chronic 
symptoms were developed by those exposed to the material. On this occasion, 
another worker was severely affected six or seven hours after leaving the same 
laboratory, and subsequently required medical treatment. As a safety precaution 
all further work in this area of imidazole chemistry was immediately suspended, 
due to a concern that continued handling of these materials could have proved 
life-threatening. However, we wished to continue the theme of acetylene-selenide 
ring closure, and our final route is described in chapter 5.
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CHAPTER 5
5. CONSTRUCTION OF THE IMIDAZOLE RING AT A LATE STAGE.
5 1 . Introduction.
Having been frustrated by the unwanted toxic side-effects of the 
imidazolylalkyne (Chapter 3) and diol (Chapter 4) intermediates in our earlier 
approaches, we wished to develop a new strategy to avoid that problem. 
Propargyl alcohols214 have proved to be very useful organic synthetic reagents, 
particularly for use as precursors to natural products such as Esperamycin215 A^ 
We believed that the use of such a species would allow us to construct the 
imidazole, at a late stage in the synthesis, from a cyclic urea.
M e S \





2-Butyne-l,4-diol was chosen as starting material, because we hoped the use of 
such a bifiinctional molecule would allow construction of both the lactone and 
imidazole portions without the hazards of a convergent synthesis. An outline of 
this idea is shown in Scheme 51. The key step is represented by the nucleophilic 
attack of nitromethane upon the imine (247). Only one literature precedent216 
exists for this type of reaction.






















problems, because comparable reactions between propargyl bromoesters and 
tributyltin hydride are known.217 This reaction occurs via a 5-exo-dig cyclisation, 
and proceeds much more rapidly with a C-C triple bond than with an alkene 
bond; presumably the higher rate results from the alkyne bond being a faster 
radical acceptor.217 That property is no doubt associated with the linear 
orientation (greater steric accessibility), and higher energy (2 n-orbitals and
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greater electron density), of the C-C triple bond.
Once access to the cyclic urea (242) had been gained, treatment with a 
halophosphorus species218 should give the a-haloimine (241). This compound 
should readily isomerise and eliminate hydrogen chloride.
5*2 Attempted functionalisation of a disubstituted alkyne.
Our initial synthetic target was the monoprotected diol (249). We envisaged at 
least two methods of synthesising this compound; protection of propargyl 
alcohol, followed by lithiation and reaction with formaldehyde, or direct 
monoprotection of 2-butyne-l,4-diol. The latter route, via the diol (250), was 
adopted because the starting material can be obtained in large quantities and 
cheaply. We chose to monoprotect the diol using dihydropyran and an acidic 
catalyst.
The literature procedure219 uses concentrated hydrochloric acid, but we 
concluded that these reaction conditions were too harsh. We chose to use a milder 
acid catalyst, namely pyridinium p-toluenesulphonate;220 however, we found that 
in practice more forcing conditions were required for the reaction to proceed, 
needing the mixture to be heated to 60-70 °C (oil bath temperature). Another 
problem was the low solubility of 2-butyne-l,4-diol in dichloromethane at room 
temperature; fortunately this is overcome by warming the mixture to 60 °C.
As expected, this reaction afforded a mixture of the mono- and diprotected 
tetrahydropyranyl alkynediols (249) and (251). However, column 
chromatography over silica gel cleanly separated the two compounds; using a 
concentration gradient from 1:199 to 1:1 ethyl acetate-light petroleum (b.p.
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60------80 °C). It is probable that an alternative preparation of the monoprotected
diol (249), from propargyl alcohol and formaldehyde, would be more efficient. 
However, we had sufficient material with which to work, and decided to 
postpone optimisation of the synthesis until we had investigated its key reactions.
Oxidation of alcohol (249), to the propargyl aldehyde (248), was readily achieved 
using tetra-npropylammonium perruthenate221 (TPAP). This reagent was selected 
because it is effective under mild non-acidic reaction conditions, which do not 
displace the tetrahydropyranyl protecting group. In the case of the alcohol (249), 
the reaction went to completion after two hours at room temperature.
As propargyl aldehydes are known to be highly air sensitive,215 the 
tetra-”propylammonium was removed by filtering the reaction mixture through a 
short pad of silica gel under a nitrogen atmosphere. We made no attempt to 
isolate the aldehyde (248), but immediately performed the reaction to form the 
inline. In order to confirm the necessity for such precautions, we demonstrated
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that removal of solvent, and exposure of aldehyde (248) to air, results in its 






TPAP = tetra-"propylammonium perruthenate
The imine (247) was prepared in situ by passing methylamine gas into dry 
methanol and adding the resultant solution to that of the aldehyde. Stirring the 
mixture at room temperature for two hours gave the desired product. Subsequent 
addition of nitromethane anion (generated with sodium methoxide) at 0 °C, 
followed by warming to room temperature, gave a single product. Isolation and 
characterisation of this material showed it to be the amide (252); see Scheme 53.
It is thought that the formation of the imine is successful, but that nitromethane is 
too poor a nucleophile - under these conditions - to attack that reactive species. 
The literature222 indicates that proton abstraction from nitroalkanes is not 
particularly easy. Scheme 52 shows the rate of ionisation of nitroalkanes at 25 °C.
k l \
B' A+ + H2CHN02 ^   ■ -  [H2C=N02]- A+ + BH
k-2
Ka(k2/k 2) pKa k_2 k2
mol min*1 mol min"1
6.1 x 10-11 10-21 41xl04 25x1 O' 6
Scheme 52. Rate of ionisation of nitromethane223 at 25 °C 
It can be seen that the equilibrium at room temperature lies heavily to the left;
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even when the mixture was refluxed there was no effect on the outcome of the 
reaction. Formation of amide (252) could result from reaction between the imine 
and water on silica gel, producing a hydroxylamine which oxidises to the amide.
MeNH










Scheme 53. Possible mechanism for the formation of amide (252).
It also appears that the desired reaction of the aldehyde (248) is hindered by the 
presence of the carbon-carbon triple bond. Its electron-releasing effect is likely to 
have a detrimental effect on the electrophilicity of the imine (247), thus reducing 
the probability of nucleophilic attack.
In order to ascertain the practicality of optimising the reaction between the imine 
(247) and nitromethane, we pursued some model chemistry. Firstly we 
investigated a reaction using isobutyraldehyde (253), and with this system we 
showed that the desired product (254) could be produced in good yield (90%). As 
this reaction proceeded smoothly, we sought to extend our model chemistry, 
using a substrate obtained from 5-valerolactone (255). All steps proceeded 
smoothly, until addition of nitromethane to the imine, formed in situ from 
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We felt this indicated that the nitromethane reaction could only be made to work 
with substrates which contained a limited range of non-reactive functionalities. 
Therefore, it seemed necessary suitably to protect the alkyne were we to continue 
with this strategy for pilocarpine synthesis. We devised the modifications 
outlined in the next section, but did not have available the time to implement 
them.
5-3 Future Work.
Nicholas224 has shown that it is possible to stabilise propargyl species by the use 
of dicobalt octacarbonyl. Such a reaction is easily achieved at room 
temperature 225 and the cobalt complex is readily displaced by either iron (III)
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nitrate or cerium (IV) ammonium nitrate. This protection not only prevents self 
condensation of the alkyne, but greatly increases both the stability and ease of 

















TPAP = tetra-^propyl ammonium pemithenate
Scheme 54.
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We expect many of these compounds would be crystalline solids, and that their 
reactivity will be lessened by the reduced availability of the four rc-electrons. A 
diminution of side-reactions should follow, making much easier the isolation of 
intermediates. We believe the application of this organometallic chemistry may 
overcome the problems we have so far encountered, and that use of these robust 






Melting points were recorded on an Electrothermal Mk. n , or a Gallenkamp 
melting point apparatus, and are uncorrected.
Elemental analyses were performed on a Carlo Erba 1106 Elemental Analyser.
Infrared spectra were determined as either a thin liquid film, a Nujol mull, or a 
chloroform solution, as stated. A Perkin-Elmer 1310 Infrared Spectrophotometer 
was used.
All n.m.r. spectra were recorded in solution using tetramethylsilane (6 0-00, s) as 
the internal standard. Assignment of signals was made by comparison with the 
most appropriate correlation table.226
*H n.m.r. spectra were recorded on either a Varian EM 360 (60 MHz) or a Jeol 
GMNGXFT-270 spectrometer (270 MHz). Multiplicities of the signals quoted 
with the spectroscopic data are; multiplet (m), quartet (q), triplet (t), doublet (d), 
and singlet (s). All values of chemical shifts and coupling constants for 60 MHz 
are approximate.
13C n.m.r. were recorded on a Jeol GMNGXFT-270 spectrometer (67.8 MHz). 
All signals were proton decoupled during acquisition. The degree of substitution 
for each atom was determined by DEPT experiments and, although not quoted, 
was at all times consistent with the assignments given. Assignments of signals 
was made with an appropriate correlation table.226
Mass spectrometry was carried out on a VG 7070 E instrument, using a VG 200
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data system. The spectra were determined under electron impact (70 or low eV), 
chemical ionisation (using isobutane), or Fast Atom Bombardment (FAB), as 
stated. Where appropriate, High Resolution (HR) accurate mass data are quoted.
Thin-layer chromatography was performed using Merck Kieselgel 60 F254 silica 
on aluminium foil plates. Plates were developed in unlined tanks, with the eluant 
stated.
Column chromatography was performed using the medium pressure227 or dry228 
“flash” techniques, with Merck Kieselgel 6 Oh  N o . 7736 silica gel, unless stated 
otherwise.
Measurement of pH was carried out using the appropriate range Whatman 
indicator paper.
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Preparation o f Diethylformylsuccinate120 (130).----- To stirred sodium-dried
ether (160 cm3), under nitrogen, was added diethyl succinate (26-5 g, 150 mmol) 
and ethyl formate (15-9 g, 200 mmol). The mixture was cooled to 0 °C, sodium 
metal (4 0 g, 0*36 mol) was added under nitrogen and the mixture was stirred for 
16-24 hours. The yellow-brown solution was quenched with water, acidified with 
2M sulphuric acid (50 cm3), extracted with ether (5 x 100 cm3), dried over 
sodium sulphate, and solvent was evaporated to give an orange oil, which was 
distilled to yield a colourless oil (25-4 g, 84%), b.p. 94-96 °C/0*03 mm (lit.120 
125-140 °C/12-15 mm)(Found: C, 53-6; H, 7-43. Calc, for C10H14O5: C, 53-5; H,
6-9%); t w  (CHCI3) 3350br (OH), 2995 (CH), 1750 (C=0), 1650 (C-O) and 
1610br cm' 1 (C=C); 8h (270 MHz; CDC13) 1 -25 (6H, t, J 1 Hz, CH2CH3), 2-60, 
2-90,* and 3-80* (2H, s, Cff2C=CHOH; t,* J  6 Hz, C//2CHCHO), 3-70, and 
11-50** (1H, t , / 2 Hz,CffCHO; d,* J 7 Hz,OH),4-15 (4H, q, J 7 Hz,Cff2CH3), 
7 00,’ and 9-90* (1H, d, /  7 Hz,CH2O C tfO H ;s 'C H O );8C(6 8 MHz; CDC13), 
13-8 (CH2CH3), 28-7 (CH2CH3), 29-5 (CH2C=CHOH), 32-5 (CH2CHCHO), 
102-9 (C=COH), 155-5 (C=CHOH), 162-3 (C02Et), 195-4 (CHO); mJz (70 eV 
El) 129 (M+-73,80%).
Signals due to aldo and enol forms.
*
Signal at 11 - 50 was removed, and signal at 7-00 collapsed to a singlet, on 
addition of D20.
2-Hydroxymethyldiethylsuccinate120 (131)------To a stirred solution of succinate
(130) (5 g, 25 mmol) in methanol (50 cm3) was added, with cooling, sodium 
borohydride (1 g, 26 mmol). The mixture was stirred at 0 °C for 2 hours, 
quenched with ice, extracted with dichloromethane (4 x 50 cm3), dried over 
sodium sulphate, and solvent was evaporated to give a yellow oil (4-38 g, 87%). 
Further purification was not necessary, (Found: C, 53 0; H, 7*9; Calc, for
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C9H160 5: C, 52-9; H, 7-8%); omax. (CHC13) 3400br (OH), 3000 (CH), 1740 
(0=0), 1380 (C02), and 1035 cm' 1 (C-O); 8h (270 MHz; CDC13) 1-25 (6H, t , / 7  
Hz, CH2C//3), 2-63 (2H, d, /  4 Hz, C//2OH), 2-77 (1H, m, /  4 and 6 Hz, 
R2C//CH2OH), 3 01 (1H, t, OH), 3-75, and 3-81 (2H, t, /  6 Hz, C7/2C 02Et), and
4-17 (4H, q , / 7  Hz, C//2CH3); 5C (68 MHz; CDC13), 13-5 (CH2CH3), 32-3 
(CH2C 02Et), 43-5 (CHCH2OH), 60 0 (CH2CH3), 61-9 (CH2OH), and 172 0 
(C02Et); mlz (lBuH Cl) 159 (M+-45,100%).
Paraconic acid112 (132).-----To a stirred and heated solution of alcohol (131)
(3 05 g, 15 mmol) in 95% ethanol (20 cm3), was added, over a period of 1 hour, 
an aqueous solution of potassium hydroxide (2-3 g) in water (100 cm3). The 
mixture was refluxed for 2 hours, cooled, 5M hydrochloric acid (50 cm3) was 
added, and the liquid was removed by evaporation. The resultant residue was 
washed with tetrahydrofuran, dried over sodium sulphate and solvent was 
evaporated. The product was a hygroscopic white solid, which was reciystallised 
from chloroform, yielding paraconic acid (132), which was stored in vacuo, (1-73 
g, 89%), m.p. 60-64 °C (lit.112 60-63 °C)(Found: C, 45-6; H, 4-8. Calc, for 
C5H60 3: C, 46 0; H, 4-6%); omax. (CHC13) 3400br (OH), 3000 (CH), 1770 
(lactone C=0), and 1720 cm' 1 (acid C=0); 8h (270 MHz; CDC13), 2-85 (2H, d, J  
8 Hz, CH2CO), 3-60 (1H, m, CffC02H), 4-55 (2H, d, /  8 Hz, CH20), and 12-50 
(1H, br s, OH); mlz (rBuH Cl) 131 (M++1,100%).
4-Hydroxymethyl-l2 ,3 ,4-tetrahydrofuran-2-one (128).------
Method 1.112 To a stirred and cooled solution of acid (132)(2-6 g, 20 mmol) 
dissolved in dry tetrahydrofuran (17-8 cm3), under nitrogen, was added a 2M 
solution, in tetrahydrofuran, of borane dimethylsulphide (12-4 cm3, 24.8 mmol).
I l l
The mixture was kept at 0-5 °C for 5 hours, then methanol was added to destroy 
any remaining borane dimethylsulphide. The resulting mixture was stirred 
overnight and concentrated, prior to the addition of more methanol (3 x 20 cm3). 
Each addition of methanol was followed by concentration, in order to ensure that 
all the borane dimethylsulphide had been removed. After the final evaporation of 
solvent, a brown-green oil was obtained (2-6 g). Chromatography of this crude oil 
over silica gel, using ethyl acetate as eluant, led to low yields of purified 
butanolide (128)(0.43 g, 32%), (Found: C, 51-4; H, 6 -88 . Calc, for C5H80 3: C, 
51-7; H, 6-89%); umax> (CHC13) 3480br (OH), 3040 (CH), 1720 (lactone C=0), 
and 1390 cm’1 (C-O); §h (270 MHz; CDC13) 2-38 (1H, dd, J  5 and 18 Hz, 3-H), 
2*64 (1H, dd, /  9 and 18 Hz, 3-H), 2-80 (1H, m, 4-H), 3-66 (2H, dd, /  3 and 6 Hz, 
CH2OH), 4-22 (1H, dd,/  5 and 9 Hz, 5-H), 4-46 (1H, dd, J 7 and 9 Hz, 5-H), and 
5 1  (1H, s, OH); 6C (68 MHz; CDC13), 31.0 (C-3), 37.0 (C-4), 62 9 (CH2OH), 
71-1 (C-5) and 178-3 (C=0); mlz CBuH Cl) 117 (AT+1,100%).
Method 2 .123 To a stirred solution of diethyl formylsuccinate (5 g, 20 mmol) in 
ethanol (40 cm3) was added slowly, with cooling, sodium borohydride (2-27 g, 60 
mmol). The reaction mixture was stirred for 2 hours at room temperature, diluted 
with 5M hydrochloric acid, filtered, and evaporated to dryness. The resulting 
residue was extracted with ethyl acetate, dried over sodium sulphate, and solvent 
was evaporated to give a yellow oil (0-97 g). The oil was dissolved in methanol 
(20 cm3) and water (10 cm3), and potassium carbonate (3 g, 20 mmol) was added. 
The solution was refluxed for 2 hours, 4M hydrochloric acid 50 cm3) was added, 
and the mixture was concentrated. The residue was extracted with ethyl acetate, 
dried over sodium sulphate, and solvent was evaporated to give a crude product 
(0.96 g), containing a mixture of components which could not be separated.
112
4-Toluenesulphonyloxymethyl-l 2 ,3 ,4-tetrahydrofuran-2-one (133).------To a
solution of alcohol (128)(0-86 g, 74 mmol) in pyridine (15 cm3) was added 
p-toluenesulphonyl chloride (2-82 g, 148 mmol) and iV//-dimethylaminopyridine 
(0.075 g, 0*6 mmol). The mixture was stirred at 0 °C for 48 hours under nitrogen, 
diluted with cold 1M hydrochloric acid (4 x 50 cm3) and extracted with ethyl 
acetate (50 cm3). The organic layer was washed with brine, dried over sodium 
sulphate, and solvent was evaporated. Chromatography over silica gel, with ethyl
acetate-light petroleum (b.p. 60------80 °C)(1:4) yielded a red-brown oil in very
poor yield (0.2 g, 10%). Insufficient sample was available for an elemental 
analysis; Dmax> (CHC13) 3001 (CH), and 1768 cm' 1 (C=0); 6h (270 MHz; CDC13) 
2-47 (3H, s, CH3), 2-75 (1H, m, C//CH20), 2-66 (2H, dd, /  9, and 18 Hz, 
CH2CO), 4 04 (4H, m, CH2S 03, OC//2CH), 7-35 (2H, d, J  8 Hz, 3’-H, and 5’-H) 
and 7-80 (2H, d, 2’-H, and 6 ’-H); 5C (68 MHz; CDC13) 21-6 (CH3), 30-5 
(CHCH2CO), 34 7 (CHCH20), 69-2 (CH2S 03), 69-3 (CHCH20), 77-4 (C-4’), 
130-1 (Ar), and 145-4 (C=0); m /z  CBuH Cl) 271 (M++1,100%).
2,5-Di(tbutyldimethylsilyl)-l-methylimidazole (139). To a solution of
di-isopropylamine (3-36 cm3, 24 mmol) in dry tetrahydrofuran (20 cm3) was 
added a 1-6M hexane solution of "butyl lithium (15 cm3, 24 mmol) at 0 °C and 
the resulting solution was stirred for 1 hour at 0 °C. A solution of
1-methylimidazole (2 g, 24 mmol) in dry tetrahydrofuran (2 cm3) was added at 
-78 °C resulting in a yellow solution. The solution was stirred for 3 hours at -78 
°C and quenched with a solution of ^ utydimethylsilyl chloride (3-6 g, 24 mmol) 
in dry tetrahydrofuran (8 cm3), producing a white precipitate. The reaction was 
warmed to room temperature poured into ice-saturated ammonium chloride 
solution, extracted with ether, dried over sodium sulphate and evaporated to give 
a yellow oil (see below) and a white solid,
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2,5-di(xbutyldimethylsilyl)-l-methylimidazole (0-425 g, 10%), m.p. 106-108 °C. 
(Found: C, 60-0; H, 11-1; N, 9-2. C16H34N2Si2 requires C, 62-0; H, 11-0; N, 
9*0%); umax. (CHC13) 2900 (CH), 2470 (C=N), 1450 (C-N) and 800 cm’1 (C-Si);
(270 MHz; CDC13), 0-29 (6H, s, (CH3)2Si-C-5), 0-39 (6H, s, (CH3)2Si-C-2),
0-89 (9H, s, (CH3)3CSi-C-5), 0-92 (9H, s, (CH3)3CSi-C-2)5 3-76 (3H, s, CH3N) 
and 7-27 (1H, s, 4-H); 5C (68 MHz; CDC13), -4-67 ((CH3)3CSi), -4-47 
((CH3)3CSi), 26-5 ((CH3)3CSi), 26-2 (NCH3), 36 0 (C-5), 130-1 (C-4) and 141-2 
(C-2); mlz (70 eV El and *BuH Cl) 311 (M++1,20%).
The reaction was repeated as above, except that the time for carbanion formation 
was halved to 90 minutes, resulting in the formation of a yellow oil,
2-xbutyldimethylsilyl-l-methylimidazole (138)(0.425 g, 90%) (Found: C, 60-7; H,
11-1; N, 11-2. C10H20N2Si requires C, 61-2; H, 10-2; N, 14-28%); omax. (CHC13) 
1460 (C=N) and 800 cm' 1 ((C-Si); 5h (270 MHz; CDC13), 1-03 (9H, s, 
(CH3)3CSi), 3-83 (3H, s, CH3N), 7-03 (1H, d ,/  2 Hz, 4-H) and 7-26 (1H, d, J  2 
Hz, 5-H); 8C (68 MHz; CDC13) -4-99 ((CH3)2Si), -3-6 ((CH3)3CSi), 17-5 
((CH3)3CSi), 34-6 (NCH3), 123-0 (C-4 and C-5); mlz CBuH Cl) 197 (M++1, 
100%).
Attempted Preparation o f 5-Benzyl-2-xbutyldimethylsily l-l -methylimidazole
(140). To a solution of di-isopropylamine (3 -36 cm3, 24 mmol) in dry
tetrahydrofuran (25 cm3) cooled to 0 °C was added a 1-6M hexane solution of 
"butyl lithium (15 cm3, 24 mmol). The solution was stirred for 1 hour, cooled to 
-78 °C and a solution of 1-methylimidazole (2 cm3, 24 mmol) in tetrahydrofuran 
(5 cm3) was added slowly, giving a yellow solution. The reaction was stirred at 
-78 °C for 1-5 hours, a solution of 'butyldimethylsilyl chloride (3-6 g, 24 mmol) 
in tetrahydrofuran (20 cm3) was added, and the mixture allowed to warm to room
114
temperature. After 3 hours the mixture was again cooled to -78 °C and a second 
equivalent of lithium di-isopropylamide was added, the mixture was stirred for
1-5 hours, and benzyl bromide (3-9 g, 24 mmol) in dry tetrahydrofuran (10 cm3) 
was added. The reaction was again warmed to room temperature, poured onto 
ice-saturated ammonium chloride, extracted with ether, dried over sodium 
sulphate, and evaporated in vacuo to give a yellow-white solid (0.415 g). 
Recrystallisation from ethanol gave a white crystalline solid, fra/u-stilbene, m.p. 
120 °C (lit.229 122 °C)(Found: C, 93-5; H, 6 -66 . Calc, for C14H12: C, 93-3; H,
6 -66%); umax, (CHC13) 3000 (Ar-H), 1580 (C=C) and 650 cm’1 (Ar-H); 8h (270 
MHz; CDCI3), 7* 19 (2H, s, CH=CH) and 7-56 (10H, m, Ar); mlz (70 eV El) 180 
(M+, 100%).
N,N-Dimethyloxamide135 (143).------To a stirred and cooled solution of 33%
(w/v) methylamine (in methylated spirits 93 cm3, 1-0 mol), in ethanol (100 cm3), 
was added slowly, over 15 minutes, diethyl oxalate (50 cm3, 0-3 mol). On 
addition of the oxalate, an immediate precipitate of A^N-dimethyloxamide was 
formed. The mixture was stirred for 2-3 hours to give needles of a white solid, 
which was recrystallised from ethanol, yielding ^//-dimethyloxamide (33.32 g, 
98%), m.p. 215-217 °C (lit.135 216-217 °C)(Found: C, 40-4; H, 7-0; N, 24-1. 
Calc, for C4H8N20 : C, 41 -4; H, 6-9; N, 24-1%); t)max (CHC13) 3385 (NH), 2940 
(CH), and 1650 cm' 1 (C=0); 6h (270 MHz; CDC13), 2-91 (6H, d , / 4  Hz, CH3) 
and 7-49 (1H, br s, NH); 6C (68 MHz; CDC13) 25-9 (CH3) and 160-3 (0=0); mlz 
(70 eVEI) 116 (M*, 100%).
5-Chloro-l-methylimidazole136 (120, X = Cl). Oxamide (143)(10-0 g, 86
mmol) was added to phosphoms pentachloride (35 g, 170 mmol) under nitrogen
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and heated cautiously to initiate the reaction (oil bath temperature 100-110 °C). 
Once the solids had partially melted the reaction was heated to 120 °C, producing 
a homogeneous solution, and kept at this temperature for 2-3 hours. Phosphoms 
oxychloride was removed from the resulting dark red-brown solution by 
distillation. Water was added cautiously, to destroy any remaining phosphorus 
pentachloride, and the mixture was heated with charcoal to remove any 
remaining dimethyloxamide. This mixture was filtered, the colourless filtrate was 
neutralised with 6M sodium hydroxide solution, and immediately extracted with 
chloroform (10 x 100 cm3). The organic phase was dried over sodium sulphate, 
and solvent was evaporated to produce a red-brown solid (5 g). Distillation gave 
a colourless oil which rapidly developed a yellow colouration (1*48 g, 15%), b.p.
38-40 °C/0-l mm, Git.140 53-54 °C/0-8 mm)(Found: C, 42-0; H, 5-2; N, 23-1. 
Calc, for C4H5N2C1: C, 41-4; H, 4-31; N, 24-1%); omax. (CHC13) 3100 (Ar-H), 
2900 (CH), 1720 (C=N) and 1650 (C=C); 8h (270 MHz; CDC13) 3*59 (3H, s, 
CH3), 6-93 (1H, s, 4-H), and 7-44 (1H, s, 2-H); 5C (68 MHz; CDC13) 31-4 
(NCH3), 1181 (CC1), 125-6 (NC=CC1) and 136-9 (NC=N); mlz (70 eV El) 116 
(M+, 80%) 118 (M++2, 30%).
Attempted preparation of2-lButydimethylsilyl-5-chloro-l -methylimidazole
(146). To a solution of freshly distilled di-isopropylamine (0- 12cm3, 0-86
mmol) in dry tetrahydrofuran (5 cm3), cooled to -78 °C, was added a 1-6M 
hexane solution of "butyl lithium (0-5 cm3, 0-86 mmol). On addition of "butyl 
lithium a white precipitate formed, indicating the formation of lithium 
di-isopropylamide. The solution was stirred at 0 °C for 1 hour in order to ensure 
complete formation of the lithiated species. The solution was again cooled to -78 
°C and a solution of (120, X = Cl) (0-1 g, 0-86 mmol) in dry tetrahydrofuran (1 
cm3) was added, producing a yellow solution which was stirred for 2 hours at -78
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°C, then quenched with a solution of 'butyldimethylsilyl chloride (0-14 g, 0-86 
mmol) in dry tetrahydrofuran (2 cm3). The reaction was then allowed to warm to 
room temperature, poured onto saturated ammonium chloride, extracted with 
ether, dried over sodium sulphate, and evaporated to give a yellow-brown oil.
Chromatography on silica gel using ethyl acetate-petroleum (b.p. 60------80
°C)(1:1) as eluant produced poor separation of the many components observed. 
Only one product could be characterised tentatively as the dimer (145). 5h (270 
MHz; CDC13), 0*87 (6H, s, (CH3)2Si), 1-25 (9H, s, (CH3)3Si), 3-95 (6H, s,
CH3N) and 7-08 (2H, s, 4-H); mlz ('BuH Cl) 310 (M+, 50%) 312 (M++2, 20%).
2- Butyldimethylsilyl-5-chloro-l-methylimidazole (146). To a stirred solution
of chloroimidazole (120, X = C1)(0-11 g, 1 mmol) in sodium-dried 
tetrahydrofuran (5 cm3) was added a 1-6M hexane solution of "butyl lithium 
(0-52 cm3, 1*3 mmol) at -78 °C. The solution was stirred for 45 minutes then a 
solution of 'butyldimethylsilyl chloride (0-15 g, 1 mmol) in dry tetrahydrofuran 
(5 cm3) was added and the reaction mixture allowed to warm to room 
temperature. The solution was quenched with water (10 cm3) and extracted with 
ether (3 x 30 cm3). The organic layer was dried over magnesium sulphate, filtered 
and evaporated in vacuo. Chromatography over silica gel using ethyl
acetate-petroleum ether (b.p. 60------80 °C) (1:49) yielded a colourless oil (0.05
g, 22%), C1oH19N2SiCl requires M, 230-8120 but fragments too rapidly therefore 
M+-57 peak (low eV El) was used; M+-57 = 173-6968 (C6H10N2SiCl requires M, 
173-6969); 5h (270 MHz; CDC13), 0-25-0-9 (15H, tBuMe2Si), 3-59 (3H, s,
NCH3) and 7-05 (1H, s, 4-H); Sc (68 MHz; CDC13) -3-6 (Si(CH3)2), 17-7 (C-2), 
25-6 ((CH3)3C), 31-6 (NCH3), 125-6 (C-4) and 137 (C-5); mlz ('BuH Cl) 230 
(M+, 20%), 232 (M++2, 20%).
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Reaction of2(5H)-Furanone with nButyl lithium. To a solution of
2(5H)-furanone (2 g, 24 mmol) in dry tetrahydrofuran (30 cm3), cooled to -78 °C, 
was added a 1-6M hexane solution of "butyl lithium (30 cm3, 48 mmol). The 
mixture was stirred at -78 °C for 90 minutes and then allowed to warm slowly to 
room temperature, at which point the mixture was quenched with ice-saturated 
ammonium chloride solution. The reaction mixture was extracted with ethyl 
acetate (2x15  cm3) and dried over sodium sulphate. Evaporation gave an 
orange-yellow oil, and chromatography over silica gel with ethyl
acetate-petroleum ether (b.p. 60------80 °C) (1:4) as eluant yielded
4-"butyloct-2-en-l,4-diol (2-3 g, 50%), (Found: C, 73 0; H, 12-3. Calc, for 
C12H24O2: C, 71-9; H, 12-1%); omax> (CHC13) 3300br (OH), 2900 (CH), and 1700 
cm' 1 (C=C); 6h (270 MHz; CDC13) 0-89 (12H, m, CH2), 1-54 (6H, m, CH3), 3-84 
(2H, br s, OH), 4-25 (2H, d, J  8 Hz, C//2CH=CH), 5-38 (1H, d, J  8 Hz,
CH2CH=CH), and 5-65 (1H, m, /  6 and 8 Hz, CH2C//=CH); 8C (68 MHz;
CDCI3) 14-2 (CH3CH2), 23-3 (CH2CH3), 26 0 (CH2CH2), 42 0 (CH2CR2OH), 
58-9 (CH2OH), 128-4 (CH2CH=CH) and 138-0 (CH2CH=CH); mlz ('BuH Cl)
201 (M++1, 20%), 143 (M+-"BuH, 100%).
Attempted preparation 5-Benzoyl-1-methylimidazole (149).-----To a solution of
oven-dried magnesium metal (0 -1 g, 4-3 mmol) in dry tetrahydrofuran (20 cm3) 
was added 5-chloro-l-methylimidazole (0-5 g, 4-3 mmol) and a crystal of iodine. 
The reaction was refluxed for 5-6 hours until a precipitate formed and the 
solution turned orange. Benzoyl chloride (0-6 g, 4-3 mmol) in dry 
tetrahydrofuran (5 cm3) was added and the reaction was refluxed for a further 2 
hours, quenched in ice-saturated ammonium chloride solution, extracted into 
ether (3x15 cm3), dried over magnesium sulphate and evaporated in vacuo to
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give a viscous orange oil. After chromatography over silica gel using ethyl
acetate-light petroleum (b.p. 60------80 °C)(1:5) as eluant, the oil gave dibenzoyl,
W C H d j )  3000 (Ar-H) and 1650 cm"1 (C=0); 5h (270 MHz; CDC13) 7-35 
(10H, m, Ar); mlz (iBuH a )  211 (M+, 20%).
N-Formyl-N-methylglycine methyl ester152,156 (163). A mixture of
methylamine hydrochloride (135 g, 2 mol), a 37% aqueous solution of formalin 
(270 cm3) and water (100 cm3) was cooled in an ice bath, and with continuous 
stirring, a cold concentrated aqueous solution of potassium cyanide (130 g, 2 
mol) was added over about 2 hours. The temperature was kept below 10 °C and a 
little solid carbon dioxide was added from time to time to maintain a carbon 
dioxide atmosphere. The reaction mixture was stirred for 1 hour and then 
extracted into a total of 1 litre of dichloromethane. After drying over calcium 
chloride and filtration, the solvent was evaporated in vacuo. The yellow oil 
obtained was dissolved in dry methanol (2-5 litres) which had been saturated with 
hydrogen chloride. The resulting solution was allowed to stand overnight, under 
nitrogen, and then refluxed for 4 hours. The reaction mixture was reduced in 
volume and the precipitated ammonium chloride was removed. The crude 
A-methylglycine methyl ester hydrochloride was dissolved by wanning in 98% 
formic acid (250 cm3). To this solution was added a hot solution of sodium 
formate (150 g) in 98% formic acid (200 cm3). After the mixture had stood for 1 
hour it was filtered through “celite” to remove the precipitated sodium chloride. 
To the remaining solution was added acetic anhydride (450 cm3), in portions, 
producing a vigorous reaction. When this had subsided, the mixture was heated at 
70-80 °C for 1-5 hours and then evaporated to remove the formic and acetic 
acids. The residual liquid was taken into 1 litre of acetone and sodium chloride 
was precipitated. The solution was then filtered, the solvent evaporated, and the
residual material, a dark brown viscous oil which contained some inorganic 
material, was distilled under reduced pressure to yield 43*4 g (18*5%) of 
N-formyl-iV-methylglycine methyl ester as a colourless oil, b.p. 86-88 °C/0-2 
mm. umax (CHC13) 1730 (C=0 ester), 1690 (C=0 aldehyde) and 1070 cm"1 
(C-O); 6h (270 MHz; CDC13) 2*4 (3H, s, NCH3), 3-1 (2H, s, NCH2CO), 3-8 (3H, 
s, C 02CH3) and 8 -1 (1H, s, CHO); mlz (70 eV El) 132 (M++1,100%).
Condensation o f N-Formyl-N-me thy I glycine methyl ester with Methyl Formate to
give enone (164).------To a stirred solution of ester (163)(43-4 g, 0*37 mol) in diy
methyl formate (70 cm3, 1-11 mol) at 0-5 °C was added, in five portions over 1 
hour, freshly prepared sodium methoxide (9-2 g, 0-4 mol) in dry benzene (75 
cm3). The sodium methoxide was prepared by dissolving sodium in dry methanol 
(16-2 cm3, 0-4 mol) and a temperature below 15 °C was maintained for 1 hour. 
The mixture (a pale cream suspension) was allowed to stand in the refrigerator 
for 18 hours. The enolate was not isolated, but a small sample was taken and 
added to ether yielding an off white solid, from which it was assumed that 
reaction had taken place.156
Methyl 2-mercapto-l-methyl-5-imidazolecarboxylate (165).------The suspension
of the sodium enolate prepared as above was shaken with water (100 cm3) 
whereupon the suspended solid dissolved and the aqueous layer was separated. 
This was then cooled in an ice bath and stirred with 36% hydrochloric acid (75 
cm3, 0-85 mol). The mixture was warmed to 60-70 °C for 2 hours, allowed to 
stand overnight and then cooled in an ice bath. A small quantity of the solid 
precipitated was collected. n.m.r. showed no signals in the aromatic region, 
and an absence of the S-H signal at 8 1-2. Attempts to retrieve any solid material
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by reducing the volume of the aqueous phase were unsuccessful, so water was 
removed in vacuo and the remaining solid was triturated with CHQ3, ethyl 
acetate, and ethyl acetate-methanol. The residual solid, which was water soluble, 
was assumed to be mostly inorganic, and a dark brown oil was obtained after 
evaporation of the organic solutions, umax (CHC13) 2040 (NCS), 1730br vw, 
1620br vw cm'1; 6h  (270 MHz; CDC13) 3-0-5 0 (m), 8 -1 (s) and 7-5 (s).
N-(a-Toluenesulphonylstyryl)formamide160,161 (170).------A solution of
toluenesulphonylmethyl isocyanide (TosMIC)(l g, 5-37 mmol) in dry 
1,2-dimethoxyethane (5 cm3) was added dropwise with stirring to a suspension of 
tBuOK (0-76 g, 5-37 mmol) in 1,2-dimethoxyethane under nitrogen between -30 
to -10 °C. To the reaction mix was added a solution of benzaldehyde (0-55 cm3, 
5-37 mmol) in 1,2-dimethoxyethane (3 cm3) at -40 °C. After stirring for 30 
minutes at -30 °C, the mixture was poured into ice-water, acidified with acetic 
acid, extracted with dichloromethane, washed with water, dried over magnesium 
sulphate, evaporated and treated with methanol at -20 °C to give a white solid, 
N-(a-toluenesulphonylstyryl)formamide (0.53 g, 33%), m.p. 150-152 °C (lit.160 
146-150 °C). (Found: C, 63-5; H, 4-94; N, 4-69. Calc, for C15H160 3S2N: C, 61-3; 
H, 4-8; N, 4-5%); omax. (CHC13), 3320 (NH), 1690 (C=0), 1645 (C=C) and 1330 
cm' 1 (S02); 8h (270 MHz; CDC13), 2-40 and 2-43 (3H, s, ArCH3 E, Z isomers), 
7-02 and 7-06 (1H, NH, E and Z isomers), 7-55 (10H, m, Ar, CH=C) and 8-06 
(1H, s, CHO); 5C (68 MHz; CDC13), 21-6 (CH3), 128-5,129-3 (C=C), 
130-6-134-7 (Ar) and 163-4 (NCOH); mlz CBuH Cl) 302 (M+, 100%).
l-Isocyano-2-phenyl-l-toluenesulphonylethene (173). To a solution of the
formamide (170) (0-1 g, 0-32 mmol) in dry 1,2-dimethoxyethane (2 cm3) at -5 °C
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was added triethylamine (0.27 cm3, 1.9 mmol), followed by the slow addition of 
phosphorus oxychloride (0.08 cm3, 0.957 mmol) in dry 1,2-dimethoxyethane (0.5 
cm3) over 5-10 minutes. The solution was then stirred for 1 hour at 0 °C to give a 
yellow-white precipitate, poured into ice-water, extracted with dichloromethane, 
dried over magnesium sulphate, evaporated and treated with methanol at -20 °C 
(CC14-C02) to give a white solid. Recrystallisation from methanol gave 
l-isocyano-2-phenyl-l-tolunesulphonylethene 50 mg (50%), m.p. 79-80 °C 
(lit.160 80 °C); nmax> (CHCI3) 2900 (CH3Ar), 2400 (C=N) and 1650 cm' 1 (C=C); 
8h (270 MHz; CDC13) 2*43 (3H, s, CH3Ar) and 7-55 (10H, m, Ar and CH=C); 
mlz CBuH Cl) 127 (M+-156, 50%) 91 (M+-192, 20%).
1-Methyl-5-phenylimidazole (174).------Methylamine (33% in methylated spirits)
(0-09 cm3, 7*76 mmol), was added to a solution of alkene (173) (0-11 g, 3-88 
mmol) in methanol (5 cm3) and stirred for 5 minutes at room temperature. After 
diluting with water, extracting with dichloromethane, drying (magnesium 
sulphate), evaporation of solvent and sublimation (80-100 °C/0*2 mm) a white 
solid was produced (50 mg, 51%), m.p. 92-94 °C (lit.160 90-94 °C). 'i)ma^  (CHCI3) 
3300 (NH) and 3000 cm’1 (Ar-H); 5h (270 MHz; CDC13) 3-6 (3H, s, NCH3) and 
7-5 (7H, m, Ar, Imid); mlz CBuH Cl) 159 (M+, 25%).
4,5-Dicyanoimidazole162 (176).----- A mixture of diaminomaleonitrile (5 g, 46-2
mmol) and triethylorthoformate (9 g, 61 mmol) in anisole (30 cm3) was heated on 
an oil bath at 135 °C for 30 minutes, whilst ethanol (7 g) was distilled out of the 
reaction mixture. Sodium methoxide (18 mg) was added and heating continued 
until no more distillate was collected. The solution was filtered hot and the 
filtrate, on cooling, produced a dark red-brown solid (5-3 g, 98%).
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Recrystallisation from water gave a pale brown crystalline solid (4*9 g, 90%), 
m.p. 174-75 °C (lit.162 175 °C) umax (nujol) 3400 (NH) and 2220 cm' 1 (CN); 5h 
(270 MHz; DMSO-D6) 8-27 (1H, s, 2-H); 8C (68 MHz; DMSO-D6) 111-3 (CN), 
115-3 (C-CN) and 141-9 (C-2); mlz flow eV El) 118 (M+, 100%).
4,5-Dicyano-l-methylimidazole. (177). To a suspension of imidazole (176) (5
g, 42 mmol) in water (50 cm3) was added slowly a solution of sodium 
hydrogencarbonate (6-72 g, 80 mmol). The reaction mixture was then heated to 
65 °C and dimethylsulphate (5*68 g, 45 mmol) was added slowly over 1 hour.
The mixture was heated for an additional hour, allowed to cool, and extracted 
with ethyl acetate, washed with saturated sodium hydrogen carbonate solution (4 
x 100 cm3), dried over sodium sulphate and evaporated to give a straw coloured 
solid (2* 14 g, 39%), m.p. 82-84 °C Git.162 84-86 °C)(Found: C, 54* 1; H, 2*96; N, 
42*2. Calc, for C6H4N2: 54*3; H, 3*03; N, 42*4%); omax. (CHC13) 3000 (CH), and 
2200 cm' 1 (CN); 5h (270 MHz; CDC13) 3*9 (3H, s, NCH3) and 7*68 (1H, s, CH); 
mlz (low eV El) 132 (M+, 100%).
1-Methyl-4,5-imidazoledicarboxy lie acid (178).------A solution of
dicyanoimidazole (177) (26 g, 196 mmol) in 6M NaOH solution was refluxed for 
2 hours with vigorous stirring. The solution was carefully acidified while hot with 
concentrated hydrochloric acid. At pH 1-2 a yellow-white solid was produced. 
The solution was allowed to cool to room temperature and the solid was filtered 
and dried to give the desired product (30*5 g, 98%). Recrystallisation did not 
improve the quality of the product, m.p. 258-260 °C (lit.162 259-260 °C)(Found: 
C, 42*2; H, 3*52; N, 16*6. Calc, for C, 42*3; H, 3*5; N, 16*4%); \>max.(Nujol)
3350 (OH), and 1700 cm"1; 5h (270 MHz; DMSO-D6) 3*80 (3H, s, NCH3), 5*6
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(2H, hr, C02H), and 9-10 (1H, s, CH); 5C (68 MHz; DMSO-D6) 37-5 (NCH3), 
128.0 (C-4), 130.0 (C-5), 138*9 (C-2) and 160*5 (C02H); mlz CBuH Cl) 170 (M+, 
100%).
1 -Methyl-5-imidazolecarboxylie acid (179).-----A suspension of
l-methyl-4,5-imidazoledicarboxylic (178) acid (7 g, 40 mmol) in acetic 
anhydride (200 cm3), dried over 4 A molecular sieves, was heated at 100 °C (oil 
bath) for 4 hours with vigorous stirring, producing a blue-black solution. The 
acetic anhydride was removed in vacuo (20 °C/5 mm) to give a grey-black solid, 
which was triturated with acetone to yield a pale grey solid (4.5 g, 95%). m.p. 
253-255 °C (lit.162 256-257 °C). umax. (Nujol) 3400 (OH) and 1760 cm’1 (C02); 
8h (270 MHz; DMSO-D6), 3*84 (3H, s, CH3), 7*61 (1H, d, J  0*94 Hz, 2-H), and 
7*94 (1H, d, J  0*94 Hz, 4-H); 8C (68 MHz; D20) 34*76 (CH3), 128*56 (C-4), 
135*63 (C-2), 141*02 (C-5) and 164*05 (C02H); mlz (low eV El) 126 (M+,
100%).
Methyl 1-methyl-5-imidazolecarboxylate (54).----- To dry methanol (20 cm3),
cooled to -45 °C, was added thionyl chloride (1*76 g, 20 mmol). After 30 
minutes, solid l-methyl-5-imidazolecarboxylic acid (1 g, 7*93 mmol) was added. 
The mixture was then allowed to warm to room temperature and subsequently 
refluxed under nitrogen for 24 hours. On cooling to 40 °C, solid sodium hydrogen 
carbonate was added to raise the pH to 8 , resulting in the production of a 
brown-orange solution after filtration. The filtrate was evaporated, the residue 
extracted with chloroform (50 cm3), and evaporated again to give a brown 
crystalline solid. Bulb to bulb distillation using Kugelrohr apparatus (60 °C/0*3 
mm) gave a colourless crystalline solid (0*5 g, 50%), m.p. 55-56 °C (lit.162 56-57
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°C)(Found: C, 51*5; H, 5-8; N, 20-1. Calc, for CgHgN^O: C, 51-4; H, 5-7; N, 
20%); umax. (CHC13) 3400 (NH) and 1700 cm' 1 (C=0); 6h (270 MHz; CDC13)
3 91 (3H, s, CH3O), 3-85 (3H, s, NCH3), 7-6 (1H, d ,/0 -9 4  Hz, 4-H), 7-71 (1H, 
d , / 0-94 Hz, 2-H); 8C (68 MHz; CDC13) 33-7 (NCH3), 51-1 (CH30), 122 4 
(C-4), 137-2 (C-2), 142-0 (C-5) and 160-3 (CH3C=0); mlz (low eV El) 140 (M+, 
80%) and 109 (M+-31,100%).
1-Methyl-5-imidazolecarboxy hydrazide156 (180).------Ester (54) (0-525 g, 3-75
mmol) was dissolved in the minimum amount of warm ethanol (2 cm3). To this 
was added an equal weight of hydrazine hydrate (10-5 mmol) and the reaction 
mixture was warmed to 40-60 °C. After 20 minutes at 40 °C a white solid began 
to precipitate out of solution, and increasing the temperature slightly led to the 
dissolution of the material. After 1 hour, the solvent was removed in vacuo and a 
white residue was produced. This was washed with dry ether and air-dried to give 
hydrazide (180)(0-465 g, 89%). m.p. 185-186 °C ait.156 188-189 °C). (Found: C, 
42-8; H, 5-71; N, 40 0. Calc, for C5HgN40 : C, 42-8; H, 5-71; N, 40-0%); umax. 
(Nujol), 3400 (NH) and 1660 cm' 1 (C=0); Sh (270 MHz; DMSO-D6) 3-50 (2H, 
br s, NH2), 3-82 (3H, s, NCH3), 7-59 (1H, s, NHC=0), 7-72 (1H, d, 70-94 Hz,
4-H) and 7-73 (1H, d, 7 0-94 Hz, 2-H); mlz (low eV El) 140 (Af+, 50%).
l-Methyl-5-imidazolecarboxybenzenesulphonylhydrazide (181). Hydrazide
(180) (0-465 g, 3-32 mmol) was suspended in pyridine (4 cm3) and to this stirred 
mixture was added 1-1 equivalents of benzenesulphonyl chloride (0-47 cm3) 
slowly. A marked colour change was observed in the mixture, from colourless to 
yellow-orange. The mixture was stirred for an additional 15 minutes and then 
diluted with water (40 cm3), affording a yellow precipitate which was
125
recrystallised from ethanol to give hydrazide (181)(0-8 g, 92%). m.p. 210-212 °C 
(lit.156 212-213 °C). (Found: C, 46-9; H, 4-17; N, 19 5. Calc, for Cn H12N40 3: C, 
471; H, 4-28; N, 19-99); nmax (Nujol) 3156 (CH) and 1660 cm' 1 (C=0); 6h (270 
MHz; DMSO-D6) 3-56 (3H, s, NCH3), 7-65 (7H, m, Ar), 9-9 (1H, s, NHCO) and
10-4 (1H, s, NHS02); mix (T3uH d )  281 (M++l, 13%) and 143 (M+-138,100%).
5-Formyl-l-methylimidazole156 (55).----- Carboxyhydrazide (181) (01 g, 0-36
mmol) was suspended in glycerol (10 cm3) and sodium carbonate (0-1 g, 0-9 
mmol) was added. The mixture was placed in an oil bath at 150-170 °C. Vigorous 
foaming was observed and the suspension rapidly became soluble in glycerol to 
give a deep orange solution. Heating was continued until foaming ceased. The 
mixture was rapidly cooled in ice, diluted with water, and extracted with 
chloroform (4 x 100 cm3). The organic phase was dried over sodium sulphate and 
evaporated to give a brown crystalline solid. Bulb to bulb distillation using 
Kugelrohr apparatus (110 °C/12 mm) gave a white crystalline solid (0.014 g, 
35%), m.p. 52-54 °C (lit.156 53-54 °C)(Found: C, 54 6 ; H, 5-61; N, 25-1. Calc, 
for C5H6N20: C, 54-5; H, 5-45; N, 25-4); \)max. (Nujol) 3300 (NH) and 1650 cm' 1 
(C=0); 5h (270 MHz; DMSO-D6) 3-90 (3H, s, NCH3), 7-92 (1H, br s, 4-H), 813 
(1H, br s, 2-H) and 9 76 (1H, s, CHO); 5C (68 MHz; DMSO-D6) 33-9 (NCH3), 
143-2 (C-4), 143-9 (C-2) and 179-3 (C=0); mlz (low eV El) 110 (M+, 100%).
5-Ethenyl-l-methylimidazole (191). To a suspension of
methyltriphenylphosphonium bromide (0-24 g, 0-67 mmol) in dry 
tetrahydrofuran (3 cm3) under nitrogen was added a 1-6M hexane solution of 
"butyl lithium (0-42 cm3, 0-67 mmol) at 0 °C.168 A bright orange colour 
immediately developed, and after 2 hours aldehyde (55) (50 mg, 0-45 mmol) in
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dry tetrahydrofuran (3 cm3) was slowly added at room temperature. The orange 
colour discharged immediately and a precipitate was observed. The resulting 
solution was stirred under nitrogen overnight, extracted with ethyl acetate (20 
cm3), and washed with ammonium chloride solution. The organic phase was 
dried over sodium sulphate and evaporated to give the crude product as a yellow 
solid (0-14 g). Chromatography on silica gel using ethyl acetate-petroleum (b.p. 
60——80 °C)(1:1) as eluant gave a white solid (triphenylphosphine oxide) and a 
pale yellow oil, ethylenylimidazole (191)(48 mg, 80%), M+ = 108-0685 (Calc, for 
C6H8N2: M, 108-0687); \>max. (CHC13) 3300 (NH) and 1740 (C=C); 8h (270 
MHz; CDC13) 5-22 (1H, d d , / l  and 11 Hz, Of=C), 5-58 (1H, d d , / 1 and 17 Hz, 
CH=C), 6-5 (1H, dd, /  11 and 17 Hz, CH2=C//), 7-2 (1H, s, 4-H) and 7-5 (1H, s,
2-H); 8C (68 MHz; CDC13) 33-8 (NCH3), 114 (CH2=C), 122-6 (CH2=C), 133-5 
(C-5), 134.2 (C-4) and 138-1 (C-2); mJz (low eV El) 108 (M+, 100%).
Attempted formation o f 5-Dibromoethenyl-l-methylimidazole15* (158).------A
solution of carbon tetrabromide (0-59 g, 1-8 mmol), triphenylphosphine (0-47 g,
1-8 mmol) and zinc dust (0-12 g, 1-8 mmol) in dry dichloromethane (8 cm3) was 
stirred under nitrogen at room temperature for 48 hours to produce a plum 
coloured solution. To this solution was added 5-formyl-l-methylimidazole (55) 
(90 mg, 0-89 mmol), an immediate precipitate was seen to form and the solution 
once again became brown in colour. The reaction was allowed to stir at room 
temperature for 4 hours, at which point t.l.c. analysis indicated no more aldehyde 
was present. Pentane was added, causing precipitation of inorganic material, 
followed by filtration and the filtrate was evaporated, and the residue was 
re-worked to extract more material. However the purified white solid obtained 
was shown to be unreacted aldehyde (55), (CHCI3) 1650 cm-1; 8jj (270 
MHz; CDCI3) 3-9 (3H, s, NCH3), 7-9 (1H, br s, 4-H), 813 (1H, br s, 2-H) and
127
9-76 (1H, s, CHO); mlz (low eV El) 110 (100%).
(Iodomethyl)triphenylphosphonium iodide174c.----- A solution of
triphenylphosphine (30 g, 115 mmol) and methylene iodide (12-8 cm3, 150 
mmol) in dry benzene (30 cm3) under nitrogen was protected from light by 
aluminium foil. The flask was fitted with a reflux condenser and the reaction 
mixture was stirred at 45 °C in an oil bath for 4 hours. After a few minutes it was 
noted that some cloudiness had developed, and after 4 hours a solid mass of the 
phosphonium salt was produced. This was filtered and washed with a small 
amount of benzene (10 cm3) to give the desired salt (22 g, 36%), m.p. 225-230 °C 
(lit.174® 230-231 °C)(Found: C, 43*2; H, 3-18; Calc, for C19H17I2P: C, 43-1; H,
3-2%).
Reaction o f 5-Formyl-l -methylimidazole with (Iodomethyl)triphenylphosphonium
iodide and nButyl lithium to give Alkene (191) and Iodoalkene (192). To a
suspension of (iodomethyl)triphenylphosphonium iodide (0-24 g, 0-45 mmol) in 
dry tetrahydrofuran (10 cm3) was added, at -78 °C, a 1-6M hexane solution of 
"butyl lithium (0-3 cm3, 0*5 mmol). This resulted in the production of an orange 
solution which was stirred at room temperature for 30 minutes, cooled to -78 °C 
and the aldehyde (55) (50 mg, 0-45 mmol) was added in dry tetrahydrofuran (2 
cm3) under nitrogen. This resulted in the immediate disappearance of the orange 
colouration and formation of a yellow-white precipitate. On stirring for 1 hour at 
room temperature, it was noted that the precipitate gradually dispersed to give a 
pale yellow solution. The reaction was subsequently washed with ammonium 
chloride solution, extracted with ethyl acetate, dried over sodium sulphate and 
evaporated to give a yellow oil. Chromatography on silica gel produced two
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products, alkene and iodoalkene, (70:30 mixture), r)max^ (CHC13) 3400 (NH) and 
1720 cm'1 (C=C). Iodoalkene (192); Sh (270 MHz; CDC13) 3-95 (3H, s, NCH3),
6-6 (2H, dd, /  9 and 15 Hz CM=CH), 7-42 (2H, dd, /  9 and 15 Hz, CHI=C//),
7-7 (1H, s, 4-H) and 8-1 (1H, s, 2-H); mlz (low eV El) 234 (M++1,100%) and 
107 (M M 28,40%). Alkene (191); §h (270 MHz; CDC13) 3-7 (3H, s, NCH3), 
5*25 (1H, d, J  12 Hz, CH= CH), 5-6 (1H, d, J  17 Hz, Cif=CH), 6-2 (1H, m, 
CH2=CH) and 7-3 (2H, s, H-4 and H-2); mlz (low eV El) 108 (M+, 20%).
5-Iodoethenyl-l-methylimidazole (192). To a suspension of
(iodomethyl)triphenylphosphonium iodide (0-3 g, 0*56 mmol) in dry 
tetrahydrofuran (12 cm3) was added slowly, at room temperature, a 1M 
tetrahydrofuran solution of sodium hexamethyldisilazane (0-56 cm3, 0-56 mmol). 
After stirring for 1 minute the solution was cooled to -78 °C and the aldehyde 
(55) (50 mg, 0*45 mmol), in dry tetrahydrofuran (2 cm3), was added under 
nitrogen, leading to a lightening of the brown colouration and formation of a 
precipitate. The mixture was allowed to warm to room temperature, and stirring 
continued for 30 minutes. The reaction mixture was subsequently washed with a 
solution of ammonium chloride and extracted with ethyl acetate, dried over 
sodium sulphate and evaporated to give a brown oil. Chromatography over silica 
gel, using ethyl acetate as eluant, isolated two compounds, the first being 
triphenylphosphine oxide and the other the halogenated alkene (192)(88 mg, 
98%), M+ = 233-9649 (C6H7IN2 requires M, 233-9655); umax. (CHC13) 3300 
(NH) and 1734 cm'1 (C=C); 5h (270 MHz; CDC13) 3-61 (3H, s, NCH3), 3-63 
(3H, s, NCH3), 6-68 (1H, dd, J  9 and 15 Hz, CIH=CH cis and trans\ 7-42 (1H, 
dd, /  9 and 15 Hz, CHI=C//), 7-7 (1H, s, 4-H) and 8-1 (1H, s, 2-H); 8C (68 MHz; 
CDC13) 31-5 (NCH3), 79-8 (ICH=C), 87-8 (ICH=CH), 130-7 (C-5), 134.2 (C-4) 
and 136.5 (C-2); mlz (low eV El) 234 (M++1,100%) and 107 (M+- l27,40%).
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5-Ethynyl-l-methylimidazole (152).------N.B. HAZARD! This compound is
highly toxic. To a solution of the iodoalkene (192)(0* 195 g, 0-82 mmol) in dry 
tetrahydrofuran (3 cm3) was added a 1-6M hexane solution of "butyl lithium (1 
cm3, 1-6 mmol) at -78 °C. The mixture was stirred at -78 °C for 30 minutes, 
giving a bright yellow solution, which was quenched on addition of water and 
subsequently extracted with ethyl acetate, dried over sodium sulphate and 
evaporated to afford a yellow oil. Chromatography over silica gel, using 
ethanol-dichloromethane (1:25) as eluant, gave two compounds, alkene (191) and 
alkyne (152) in a 60:40 ratio, uma3L (film) 3450 (O CH ), 2990 (CH) and 2100 
cm' 1 (C=C); 6h (270 MHz; DMSO-D6) 3*62 (3H, s, NCH3), 4 66 (1H, s, OCH ),
7-14 (1H, s, 4-H) and 7-59 (1H, s, 2-H); mlz (low eV El) 106 (M+, 100%).
Attempted Alkylation o f 5-Ethyny l-l-methylimidazole.------To a solution of the
alkynylimidazole (152)(0* 12 g, 0*5 mmol) in dry tetrahydrofuran (5 cm3) at -78 
°C was added 'butyl lithium (0-35 cm3, 0-5 mmol). The reaction mixture was 
allowed warm to room temperature and stirred for 30 minutes. "Butyl lithium 
(0-35 cm3, 0-5 mmol) was added, producing a yellow solution, the solution was 
stirred for a further 30 minutes at room temperature and then quenched with a 
large excess of ethyl 2-bromobutyrate (5 g, 27-9 mmol). Stirring was continued 
for another hour, after which all cloudiness disappeared to give a yellow solution. 
The reaction mixture was washed with brine (5 cm3), extracted with ethyl acetate, 
dried over sodium sulphate and evaporated in vacuo producing a yellow oil. 
Chromatography over silica gel, using ethanol-dichloromethane (1:25) as eluant, 
yielded one major compound, which was identified as a dimer of the bromoester 
(195) (0-1 g, 60%), umax. (CHC13) 1700 cm’1 (C=0); 5h (270 MHz; CDC13) 0-96
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(6H, t, /  7 Hz, Gtf3CH2), 1*2 (6H, t, /  7 Hz, Ctf3CH20), 2 0 (4H, m, /  5*9 and 7 
Hz, CH3C/f2CHCO), 4 2 (4H, dq, J 1 Hz, CH3C//2C 02) and 4 53 (2H, dt, /  5*9 
and 7 Hz, CHCO); m/z (70 eV El and T3uH Cl) no mass peak observed.
Attempted Protection ofAlkyne (152) with xButyldimethylsilyl chloride11*. To
a solution of the iodoalkene (192) (0-12 g, 0-5 mmol) in dry tetrahydrofuran (4 
cm3) under nitrogen, cooled to -78 °C, was added a 1*6M hexane solution of 
"butyl lithium (1 cm3, 1*53 mmol) and the resulting mixture was left to stir at -78 
°C for 2 hours. *Butyldimethylsilyl chloride (0 -12 g, 1 mmol) in dry 
tetrahydrofuran (3 cm3) was added and the reaction allowed to warm to room 
temperature. The crude reaction mixture was poured into water, extracted with 
ethyl acetate (3x 20 cm3), dried over sodium sulphate, and evaporated in vacuo to 
give a yellow oil silylalkenylimidazole (196)(60 mg, 60%), 5h (270 MHz;
CDC13) 0-9 (15H, s, (CH3)3Si(CH3)2), 3-5 (3H, s, NCH3), 5-2 (1H, dd, /  1 and 11 
Hz, C/f2=CH), 5*6 (1H, dd, /  1 and 18 Hz, CH2=CH), 6-4 (1H, m, CH2=CH) and
7-3 (1H, s, 4-H); 8C (68 MHz; CDC13) 19-7 ((CH3)3C), 31.4 ((CH3)2Si), 35 0 
(C-Si), 122*2 (SiC=C), 126*0 (SiC=C) and 144*8 (C-4); m/z (70 eV El) 223 
(M++1, 80%).
Attempted alkylation o f Phenylacetylene (199).------To a stirred solution of
phenylacetylene (0*5 g, 4*89 mmol) in dry tetrahydrofuran (7 cm3) cooled to -78 
°C, was added a 1-6M hexane solution of "butyl lithium (3 cm3, 4*89 mmol). This 
produced a cloudy orange solution which was allowed to stir for 1 hour at room 
temperature. The reaction was then quenched with 1*5 equivalents of ethyl
2-bromobutyrate (2 g, 7*3 mmol). The cloudiness of the solution was 
immediately seen to disappear and the reaction mixture was stirred for an
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additional 30 minutes at room temperature, washed with brine and extracted with
i
ethyl acetate to give a yellow solution. The organic phase was dried over sodium 
sulphate and evaporated in vacuo producing an orange-yellow oil. T.l.c. analysis 
indicated the presence of one new component, but attempts at column 
chromatography lead to further decomposition. A further repetition of this 
reaction, followed by bulb to bulb distillation using Kugelrohr apparatus, 
succeeded only in the recovery of unreacted bromoester.
5-(1,3-Dithian-2-yl)-l-methylimidazole trifluoroborate (206).------To a solution
of the aldehyde (55) (0-2 g, 1-8 mmol) in dry dichloromethane (10 cm3) under 
nitrogen was added 1 equivalent of propane-1,3-dithiol191 (0-19 g, 1-8 mmol). 
The mixture was cooled to 0 °C and borane trifluoride etherate (0-64 g, 4-54 
mmol) was added slowly. An immediate precipitate formed which persisted for 1 
hour, and the solution then became clear and was stirred at room temperature for 
an additional 2 hours. The reaction was washed with brine, extracted with ethyl 
acetate, dried over sodium sulphate, and evaporated in vacuo to give a white solid
5-(1,3-dithian-2-yl)-l-methylimidazole trifluoroborate (0-3 g, 90%), m.p.
105-107 °C (Found; C, 29*8; H, 4-12; N, 8-5. C8H15N2S202BF3 requires C, 29-9; 
H, 3-8; N, 8-7%); nmax. (Nujol) 3400 cm' 1 (C=N); 5h (270 MHz; DMSO-D6)
1-85 (1H, m, SCH2C//2), 2 07 (1H, m, SCH2C//2), 3 00  (4H, m, J  3, 6 and 10 
Hz, SCH2), 3-88 (3H, s, NCH3), 5-71 (1H, s, SCHS), 7-81 (1H, s, 4-H) and 9 07 
(1H, s, 2-H); 8C (68 MHz; DMSO-D6) 24-4 (CH2CH2CH2), 28-9 (CH2S), 35-8 
(SCHS), 38*8 (NCH3), 118-4 (C-4), 132-3 (C-5) and 136.0 (C-2); mlz CBuH Cl) 
201 (M+, 80%).
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Conversion o f 5-( 1 $-Dithian-2-yl)-l -methylimidazole trifluoroborate to
5-(l ,3-Dithian-2-yl)-l -methylimidazole (205). To a suspension of the
trifluoroborate (0.07 g, 0-37 mmol) in dry tetrahydrofuran (3 cm3) was added a
1-6M hexane solution of "butyl lithium (0-23 cm3, 0-37 mmol) at -78 °C. An 
immediate yellow solution developed which was stirred at -78 °C for 2 hours and 
then quenched with brine and allowed to warm slowly to room temperature, 
extracted with ethyl acetate, dried over sodium sulphate and evaporated in vacuo 
to give a white solid 5-(1,3-dithian-2-yl)-l -methylimidazole (25 mg, 60%), m.p. 
120-122 °C; M+ = 200-0440 (C8H12N2S2 requires M, 200-0428); (Found: C, 47-6; 
H, 6-0; N, 13-3. C8H12N2S2 requires C, 48-0; H, 6-0; N, 14%); umax. (CHC13) 
3300 (NH) and 1220 cm' 1 (S-CH2); 5** (270 MHz; CDC13) 1-97 (1H, m, /  2, 6 
and 10 Hz, SCH2C//2), 2-0 (1H, m, SCH2O f2), 3-0 (4H, m, (SCtf2)2), 3-73 (3H, 
s, NCH3), 5-22 (1H, s, SCHS), 7-13 (1H, s, 4-H) and 7-44 (1H, s, 2-H); 8C (68 
MHz; CDC13) 25-0 (SCH2CH2CH2S), 31-4 (SCH2), 32-0 (NCH3), 40-0 (SCH), 
128-9 (C-4) and 139 (C-2); m/z (70 eV El) 200 (M+, 80%).
Deuteration Studies on 5-(l,3-Dithian-2-yl)-l-methylimidazole (205). To a
solution of dithiane (205)(0.055 g, 0-27 mmol) in dry tetrahydrofuran (2 cm3) 
under nitrogen, at -78 °C, was added a 1-6M hexane solution of "butyl lithium 
(0-16 cm3, 0-27 mmol). An immediate orange-brown colour developed, and the 
solution was stirred for 1 hour at -78 °C to ensure complete formation of the 
anion. The reaction mixture was then warmed to room temperature and quenched 
with D20  (0-2 cm3), with simultaneous discharging of the orange colour. The 
mixture was stirred at room temperature for 30 minutes to ensure complete 
quenching, giving a pale yellow solution which was extracted with chloroform, 
washed with brine, dried over sodium sulphate and evaporated in vacuo to yield a 
white solid 2-deutero-5-(1 j -Dithian-2-yI)-1 -methylimidazole (0.04 g, 72%), m.p.
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120-122 °C. vmaI (CHa3) 3400 (NH) and 1100 cm' 1 (SCH); 5h (270 MHz; 
CDC13) 1-94 (1H, m, SCH2CH2), 2-13 (1H, m, SCH2Cff2), 2-94 (4H, m, SCH2),
3-73 (3H, s, NCH3), 5-24 (1H, s, SCHS), 7-1 (1H, s, 4-H) and 7-3 (<1H, s, 2-H); 
5C (68 MHz; CDC13) 24-8 (SCH2CH2CH2S), 27-7 (SCH2CH2), 31-9 (NCH3),
39-9 (SCH2S), 128-8 (C-4) and 139-2 (C-2); mlz CBuH a )  201 (M++1, 100%).
Methylation o f 5-(l,3-Dithian-2-yl)-l-methylimidazole (205).------To a solution
of imidazole (205) (0-1 g, 0-6 mmol) in dry tetrahydrofuran (10 cm3), cooled to 
-78 °C, was added a 1-6M hexane solution of "butyl lithium (1 cm3, 1-15 mmol). 
This produced a clear yellow solution which was stirred for 2 hours at -78 °C, 
quenched with methyl iodide (0 * 1 cm3, 1*8 mmol) and slowly warmed to room 
temperature to give a cloudy yellow solution. Extraction with chloroform (3x5  
cm3), washing with brine (3x5 cm3) afforded a yellow solution which was dried 
over magnesium sulphate and evaporated in vacuo to yield a yellow oil (0 -13 g, 
96%). T.l.c. analysis, using ethanol-dichloromethane (1:25) as eluant, showed a 
single component and further purification was not required, vmaXi (CHCI3) 2900 
(CH) and 1200 cm' 1 (SCH); 5h (270 MHz; CDC13) 1-94 (1H, m, SCH2C//2), 2-0 
(3H, s, CH3CS), 2-57 (1H, m, SCH2Ctf2), 2-91 (4H, m, SCH2), 3-90 (3H, s, 
CH3N), 4 00 (3H, s, CH3), 7-27 (1H, s, 4-H) and 7-40 (>1H, s, 2-H); mlz (70 eV 
El) 229 (M++1,45%).
2-xButyldimethylsily l-5-(l,3-dithian-2-yl)-l-methylimidazole (210).------To a
solution of thioacetal (205) (0.055 g, 0-28 mmol) in dry tetrahydrofuran (2 cm3) 
under nitrogen at -78 °C was added a 1-6M hexane solution of "butyl lithium 
(0-16 cm3, 0-28 mmol). An immediate orange brown colour developed, as before, 
and the reaction mixture was stirred for 1 hour at -78 °C to ensure complete
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formation of the anion. /Butyldimethylsilyl chloride (0.045 g, 0-28 mmol) in dry 
tetrahydrofuran (2 cm3) was added and the solution was stirred at room 
temperature for 2 hours. The reaction mixture was subsequently extracted with 
chloroform, washed with brine, dried over sodium sulphate and evaporated in 
vacuo to give a yellow-white solid
2-Butryldimethylsilyl-5-(l,3-dithian-2-yl)-l-methylimidaiole (0.08 g, 90%). m.p. 
170-172 °C (Found: C, 53-5; H, 8-58; N, 8-5. C14H26N2S2Si requires: C, 53-5; H,
8-28; N, 8-9 %); o w  (CHC13) 3200 (NH), 1250 (SiCH3) and 650-800 cm' 1 
(SiC); 8h (270 MHz; CDC13) 0-3 (6H, s, Si(CH3)2), 0-85 (9H, s, SiC(CH3)3),
1-82 (1H, m, SCH2C//2), 1*87 (1H, m, SCH2Ctf2), 2-94 (4H, m, (SCH2)2), 3-7 
(3H, s, NCH3), 5* 14 (1H, s, SCHS) and 7* 19 (1H, s, 4-H); 8C (68 MHz; CDC13) 
-4-8 (Si(CH3))2, 24-9 (SCH2CH2CH2S), 25-6 (SiC), 26-4 (SiC(CH3)3), 31-5 
SCH2), 32-7 (NCH3), 40-5 (SCHS), 129-9 (C-4) and 131 (C-2); mlz CBuH Cl) 
315 (M++1, 78%), 257 (Af+-57,100%).
Attempted Michael Addition of
2-tButyldimethylsilyl-5-(l,3-dithian-2-yl)-l-methylimazole (210) to
2(5H)-Furanone. To a solution of thioacetal (210) (0.02 g, 0-065 mmol) in
dry tetrahydrofuran (2 cm3) was added "butyl lithium (0-04 cm3, 0-065 mmol) at 
-78 °C and the mixture was stirred for 2 hours. Freshly distilled 2(5H)-furanone 
(0-01 cm3, 0-065 mmol) was added and the mixture stirred for a further 30 
minutes at -78 °C, producing a pale yellow solution. This was subsequently 
quenched with iodoethane (0-195 g, 1 -25 mmol) and allowed to warm slowly to 
room temperature, and extraction with chloroform to give a yellow gum (50 mg). 
Only starting material could be isolated after chromatography over silica gel 
using chloroform as eluant.
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Attempted 1,4-Addition to 2(5H)-Furanone using imidazole (210) and Copper (I)
iodide. To a stirred solution of the thioacetal (210) (0.086 g, 0-43 mmol) in
dry tetrahydrofuran (3 cm3) cooled to -78 °C was added "butyl lithium (0-54 cm3,
0-86 mmol). The resulting orange solution was stirred for 2 hours at -78 °C, dried 
cuprous iodide (0.081 g, 0-43 mmol) was added, and the was reaction stirred for 
an additional hour. The solution became dark brown and the cuprous iodide was 
seen to dissolve. Freshly distilled 2(5H)-fiiranone was added (0 03 cm3, 0-4 
mmol) and the solution immediately lightened in colour, subsequently becoming 
cloudy and grey on standing. The resulting mixture was stirred for 2 hours then 
quenched with water at -78 °C and slowly warmed to room temperature, 
producing a grey precipitate. The material was extracted with chloroform and 
washed with ammonium chloride solution, dried over sodium sulphate, and 
evaporated in vacuo to give a yellow oil (20 mg). Chromotogaphy over silica gel,
using ethyl acetate-light petroleum (b.p. 60------80 °C)(1:1) as eluant, gave two
major products corresponding to starting materials.
Attempted Reaction of
2-xButyldimethylsilyl-5-(l ,3-dithian-2-yl)-l-methylimidazole (210) with Ethyl
acrylate. To a solution of thioacetal (205)(0-1 g, 0-5 mmol) in dry
tetrahydrofuran (2 cm3), cooled to -78 °C, was added a 1-6M hexane solution of 
"butyl lithium (0-31 cm3, 0*5 mmol). The mixture was stirred for 1 hour at -78 °C 
then quenched with 'butyldimethylsilyl chloride (75 mg, 0*5 mmol) and warmed 
to room temperature. After quenching was complete (2 hours), the reaction was 
again cooled to -78 °C and a second equivalent of "butyl lithium (0-31 cm3, 0*5 
mmol) was added to give a deep orange solution which was stirred for 1 hour. 
Ethyl acrylate (0.05 g, 0-5 mmol) was added and the mixture was warmed to -50
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°C, quenched with water, allowed to warm to room temperature overnight, 
extracted with ethyl acetate, washed with water, dried over sodium sulphate, and 
evaporated to give a white solid (16 mg), which contained only starting material.
Ethyl2-formylbutyrate195 (219). A solution of di-isopropylamine (5-06 g, 50
mmol) in dry tetrahydrofuran (50 cm3) was treated with a 1-6M hexane solution 
of "butyl lithium at 0 °C (31 *2 cm3, 50 mmol) to give a yellow solution which 
was stirred for 1 hour at 0 °C and then cooled to -78 °C. A solution of ethyl 
butyrate (5-81 g, 50 mmol) in dry tetrahydrofuran (15 cm3) was added, the 
resulting mixture was stirred for 30 minutes at -78 °C, ethyl formate (11 • 1 g, 150 
mmol) added, and the mixture allowed to warm to room temperature. Acetic acid 
was added (9 g), excess tetrahydrofuran was removed before the solution was 
diluted with ether, washed with water (2x 100 cm3) and saturated sodium 
hydrogen carbonate solution, dried over sodium sulphate, and evaporated in 
vacuo to give a pale yellow oil which was distilled to afford a colourless oil (2.9 
g, 40%) b.p. 70-72 °C/15 mm (lit.157 76-81 °C/23 mm).(Found: C, 57-9; H, 8 -8 ; 
Calc, for C7H120 3: C, 58*3; H, 8-3%); omax. (CHC13) 3500 (OH) and 1700 cm' 1 
(C=0); 5h (270 MHz; CDC13) 1 03 (3H, t, J 1 Hz, Ctf3CH2), 1*35 (3H, t, /  7 Hz, 
Ctf3CH2CO), 2 2 (2H, m, / 7  Hz, CH3C/f2), 3-34 (0-5H, dt, / 2 , 7  Hz, CH), 4-27 
(2H, q , / 7  Hz, CH3Ctf2CO), (0-5H, d , / 2  Hz, CHO) and 11-41 (0-5H, d , /  12 
Hz, OH); mlz CBuH Cl) 145 (M++1,100%).
Ethyl 2-hydroxymethylbutyrate (220).------To a solution of ethyl 2-formylbutyrate
(219)(2 g, 14 mmol) in methanol (20 cm3), stirred at 0 °C, was added slowly 
sodium borohydride (0-52 g, 30 mmol). The mixture was stirred for 4 hours at 0 
°C, neutralised with 2M hydrochloric acid, excess methanol was removed, the
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mixture was washed with saturated ammonium chloride and extracted with ether. 
The organic phase was dried over sodium sulphate and evaporated in vacuo to 
give a yellow oil ethyl 2-hydroxymethylbutyrate (220) (0.19 g, 97%)(Found: C, 
56-8; H, 9-87. C7H140 3 requires: C, 57-5; H, 9-6%); omax. (CHC13) 3420 (OH) 
and 1700 cm’1 (C=0); 8h  (270 MHz; CDC13) 0-95 (3H, t , /7 H z , CH3CH2CH),
I-29 (3H, t, J  7 Hz, Ctf3CH20), 1-65 (2H, m, J  7 and 12 Hz, CH3Ctf2C), 2-38 
(1H, br s, OH), 2-51 (1H, m, CH2Ctf), 3-74 (2H, dd, /  8 and 12 Hz, CH2OH) and
4-18 (2H, q ,77  and 12 Hz, CH3Ctf20); 8C (68 MHz; CDC13); 11-5 (CH3CH2),
II-7 (CH3CH20), 21-6 (CH3CH2CH), 48-9 (CHCO), 60-2 (CH2CO), 62-7 
(CH20 ) and 171 -6 (CO); mlz ('BuH a )  147 (M++l, 95%).
Attempted preparation o f Ethyl 2-bromomethylbutyrate196497 (221).------To a
stirred solution of butyrate (220)(0-25 g, 1-71 mmol) in dry tetrahydrofuran (5 
cm3) was added carbon tetrabromide (1 *7 g, 5-1 mmol). After stirring for 5 
minutes, triphenylphosphine (0-22 g, 2-5 mmol) was added in dry tetrahydrofuran 
(10 cm3). The mixture was stirred at room temperature for 24 hours and, as no 
significant change had been observed, the reaction was refluxed for 3-4 hours, 
extracted into ether, washed with ice-saturated ammonium chloride, dried over 
sodium sulphate and evaporated in vacuo to give a brown oil (50%).
Chromatography over silica gel with ethyl acetate-light petroleum (b.p. 60------80
°C)(1:1) as eluant produced a mixture of triphenylphosphine oxide and 
tribromomethane, but no starting material was isolated. The reaction was 
repeated in the absence of any solvent, carbon tetrabromide (6*81 g, 20 mmol) 
and triphenylphosphine (2-69 g, 10-3 mmol) were heated together until the 
mixture melted. The reaction was cooled slightly and 2-hydroxymethylbutanoate 
(1 g, 6*8 mmol) was added. Much effervescence was observed and after heating 
for 3 hours a blood-red solution was produced. The reaction was extracted into
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ether, washed with ammonium chloride, dried over sodium sulphate and 
evaporated to give a red oil. Chromatography on silica gel using ethyl
acetate-light petroleum (b.p. 60------80 °C)(1:1) as eluant afforded an
orange-yellow oil (1-4 g, 50%). None of the starting material and no product 
were present.
Ethyl 2-bromomethylbutanoate100 (221). To a solution of ethyl
2-hydroxymethylbutanoate (1 g, 6*8 mmol) in dry pyridine (5 cm3) was added 
slowly, and with cooling at 0 °C, phosphoms tribromide (0-6 g, 2*2 mmol). An 
immediate yellow-white precipitate was formed and the reaction mixture was 
stirred for 4 hours at 0 °C and then for 2 hours at room temperature. The reaction 
mixture was extracted with ether, washed with ice-water, dried over sodium 
sulphate and evaporated to give a pale yellow oil. Chromatography over silica gel
using ethyl acetate-light petroleum (b.p. 60------80 °C)(1:9) as eluant yielded a
pale yellow oil ethyl 2-bromomethylbutanoate (510 mg, 58%)(Found: C, 43-9; H,
7-05. C7H130 2Br requires C, 40-2; H, 6-2%); (film); 1720 (C=0); 6h (270 
MHz; CDC13) 0-94 (3H, t, J 7 Hz, C//3CH2CH), 1-28 (3H, t, /  7 Hz, C//3CH20), 
1*68 (2H, m, CH3C//2CH), 2 73 (1H, m, C//CH2), 3-3 (2H, dd, /  7 and 14 Hz, 
CHC//2Br) and 4* 19 (2H, q, /  7 and 14 Hz, CH3Ctf20); 5C (68 MHz; CDC13) 
11*4 (CH3CH2), 14 2 (CH3CH2C), 24 3 (CH3CH2CH), 32* 1 (CH2Br), 49-5 
(CHCO), 60-7 (CH2CO) and 173 (C02Et); m!z (‘BuH Cl) 211 (M++2, 60%) and 
209 (M+ 60%).
Ethyl 2-methylphosphoniumbutanoate bromide (215).-----To a solution of
butanoate (221) (0-225 g, 0-95 mmol) in dry toluene was added 
triphenylphosphine (0-32 g, 1-4 mmol), and the mixture was refluxed for 12
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hours then slowly cooled to room temperature, to produce a yellow white gum. 
The remaining toluene was decanted along with any unreacted 
triphenylphosphine, and the crude bromide (215)(0-15 g, 30%) was dried and 
used in the next step without further purification, (270 MHz; CDC13) 0-95 
(3H, br t, /  7 Hz, Ctf3CH2CH), 1 ‘02 (3H, br t, J 1 Hz, Ctf3CH20), 1 90 (2H, m, 
CH3C/f2), 2-82 (1H, br m, C/fCH2), 3-49 (2H, q ,/  8 Hz, CH3C/f20), 3-64 (2H, 
br dd, CH2P) and 7-85 (15H, m, Ph); 6C (68 MHz; CDC13) 10-9 (CH3CH2C), 
13-6 (CH3CH20), 27-5 (O ^C H j), 27-6 (CH2P), 40-8 (CH), 60-9 (CH20), 
116-135 (Ph) and 173-6 (C=0); mlz (FAB +) 391 (M+, 50%), 279 (OPPh3, 
100%).
2-Hydroxymethylbutanoic acid (222). To a solution of butyrate (220) (0-5 g,
3 -4 mmol) in ethanol (10 cm3) was added a large excess of 2M NaOH (10 cm3). 
The mixture was refluxed for 3 hours, concentrated to half its original volume, 
was cooled, and 2M sulphuric acid was added to raise the pH to 5. The solution 
was extracted into ether, which was washed with saturated ammonium chloride 
solution, dried over sodium sulphate and evaporated to give a yellow oil (0-3 g, 
72%), which was distilled at reduced pressure to produce a colourless oil, b.p. 
102-104 °C/0-3 mm (lit.197* 102-104 °C/0-25 mm) (Found: C, 50-4; H, 8-2. Calc. 
forC5H10O3: C, 50-8; H, 8-47%); umax. (CHC13) 3400 (OH) and 1700 cm"1 
(C=0); 8h (270 MHz; DMSO-D6), 0-93 (3H, t, 7 7 Hz, C//3CH2), 1-53 (2H, q, 7 
7 and 10 Hz, CH3Ctf2), 2-35 (1H, q, 7 7 and 14 Hz, CH), 3-55 (2H, dq, 7 5  and 
14 Hz, CH2-0 ) and 12 00 (1H, br s, OH); 8C (68 MHz; DMSO-D6), 11-9 
(CH3CH2), 21-5 (CH3CH2), 50 0 (CH), 62-2 (CH2OH) and 176-1 (C02H); mlz 
(T3uH Cl) 119 (M++l, 20%) and 101 (A/+-18,100%).
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Attempted Protection of2-Hydroxymethylbutanoic acid203 to give oxazoline
(223). To a stirred solution of 2-hydroxymethylbutanoic acid (0-08 g, 0-67
mmol) in dry toluene (5 cm3) was added 2-amino-2-methyl-1 -propanol (0 -18 g, 2 
mmol). The reaction mixture was then refluxed for 24 hours, after which toluene 
was removed giving a yellow viscous gum which was insoluble in all solvents 
tried and could not be characterised.
Attempted Wittig Reaction between Ethyl 2-methylphosphoniumbutanoate
bromide (215), nbutyl lithium and Benzaldehyde to give alkene (224). To a
suspension of phosphonium bromide (215)(0-15 g, 0-32 mmol) in dry 
tetrahydrofuran (5 cm3) cooled to -78 °C was added a 1*6 M hexane solution of 
”butyl lithium (0-2 cm3, 0-32 mmol), and the mixture was stirred for 1 hour at -78 
°C producing a clear orange solution. Freshly distilled benzaldehyde (0 04 g,
0-32 mmol) was added and the orange colour immediately disappeared. The 
reaction was slowly allowed to warm to room temperature, poured into ice-water, 
extracted with ether, dried over sodium sulphate and evaporated to give a yellow
oil. Chromatography, using ethyl acetate-light petroleum (b.p. 60------80
°C)(1:99) as eluant, on silica gel yielded a number of components, including 
starting material, and the double bond migration product, alkene (224) (20 mg, 
30%), omax. (CHC13) 1700 cm'1; 5h (270 MHz; CDC13) 0-91 (3H, br t, /  7 Hz, 
C//3CH2), 1 • 26 (3H, t, /  7 Hz C//3CH20), 1.74 (4H, br q, CH2), 2.31 (2H, d, J 1 
Hz, CH2Ar), 5.65 (1H, t, /  8 Hz, C=CH), and 7.35 (5H, m, Ar); mlz CBuH Cl) 
219 (M+, 0.8%).
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Attempted Olefination of 5-Formyl-l -methylimidazole with Ethyl
2-methylphosphoniumbutanoate bromide (215). To a solution of the
phosphorane (018 g, 0 37 mmol) in dry tetrahydrofuran (3 cm3) under nitrogen 
was added a 1-6M hexane solution of "butyl lithium (0-25 cm3, 0.3 mmol) at -78 
°C. The solution became yellow immediately, and was stirred at -78 °C for 20 
minutes, then l-methyl-5-carboxyimidazole (0.005 g, 0*37 mmol) in dry 
tetrahydrofuran (2 cm3) was added and the reaction allowed to warm to room 
temperature, washed with brine, extracted into ethyl acetate, dried over sodium 
sulphate and evaporated to give a yellow viscous oil. Chromatography on silica
gel with ethyl acetate-light petroleum (b.p. 60------80 °C)(1:1) produced two
compounds which were identified as triphenylphosphine oxide and unreacted 
aldehyde.
Attempts to prepare 1-Methyl-5-oxiranylimidazole. (233). To a suspension of
metar-chloroperoxybenzoic acid (m-CPBA) (0*32 g, 1-85 mmol) in dry 
dichloromethane (4 cm3) under nitrogen was added 5-ethenyl-l-methylimidazole 
(191)(0-1 g, 0*92 mmol) in dry dichloromethane (2 cm3). The solution was seen 
to become yellow on the initial addition but after 30 minutes a white precipitate 
began to form and this was seen to increase with time. The mixture was left to 
stir at room temperature for 24 hours poured into water and shaken with saturated 
sodium hydrogen carbonate solution, extracted with CHC13 (3x10  cm3), dried 
over magnesium sulphate and evaporated to give a yellow viscous oil (65 mg, 
65%). However proton n.m.r. showed that this was unreacted alkene.
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Attempted formation o f 1 -Methyl-5-oxiranylimidaiole using Corey’s Ylide,210
yielding alkene (239). To a flask purged with nitrogen was added sodium
hydride (0.03 g, 0 -12 mmol) and trimethyloxosulphonium iodide (0-26 g, 0* 12 
mmol). Dimethylsulphoxide (5 cm3) was added slowly, resulting in the rapid 
liberation of hydrogen and the production of a cloudy solution, which was stirred 
for 15 minutes at room temperature and 5-formyl-l-methylimidazole (55) (0-1 g,
0-9 mmol) in dry DMSO (1 cm3) was added slowly. Stirring was continued for 3 
hours at room temperature producing a blood-red solution, which was washed 
with water and extracted with ethyl acetate to give a glassy yellow oil (0-22 g, 
95%), which proved not to be the epoxide but the dimethylsulphoxyalkene (239), 
M+ = 170 04691 (C7H10N2OS requires M, 170-2288); umax. (CHC13) 3400 (NH), 
1620 cm' 1 (C=C); 8h (270 MHz; CDC13) 2-62 (6H, s, SCH3), 3-95 (3H, s, 
NCH3), 6-78 (1H, d , /  15 Hz, CH= C), 7-13 (1H, d , / 15 Hz, C=CH), 7-38 (1H, s, 
4-H), and 7-5 (1H, s, 2-H); 5C (68 MHz; CDC13) 29-7 (NCH3), 41-0 (SOCH3), 
121 (RS02HC=C), 128 (RS02HC=C), 130*6 (C-4), 132 (C-2) and 140 (C-5); mlz 
(low eV El) 170 (M+, 78%).
1-Methyl-5-oxirany limidazole11^  (233).------N.B. HAZARD! This compound is
highly toxic. To a solution of alkene (191) (0.065 g, 0*59 mmol) in diy benzene 
(5 cm3) and a catalytic amount of vanadyl acetylacetonate (0.002 g, 0 -01 mmol) 
was added, with refluxing a 3M 2,4,4-pentane solution of 'butylhydroperoxide 
(0* 19 cm3, 0-59 mmol) over 5-10 minutes. On addition of the vanadyl 
acetylacetonate, the solution became blue-green and on heating this colour faded 
slightly. Addition of 'butylhydroperoxide resulted in an immediate orange-red 
colouration, but after heating the reaction mixture for 2 hours the orange colour 
faded to yellow-brown, and after 4 hours the solution turned green. The organic 
phase was washed with aqueous bisulphite, dried over sodium sulphate and
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evaporated to give a brown oil (11 mg). However this proved to be unreacted 
starting material and the major product, believed to be the diol (240), was found 
in the aqueous phase but was so toxic it could not be characterised.
Pyridinium -para-toluenesulphonate220------To diy pyridine (12 cm3) was added
para-toluenesulphonic acid monohydrate (95-7 g, 72 mmol) and the resulting 
mixture was stirred for 20 minutes at room temperature. The excess pyridine was 
removed in vacuo to give a yellow-white solid which was recrystallised from 
acetone to yield solid pyridinium para-toluenesulphonate (6-8 g, 60%). m.p. 
116-118 °C (lit.220 120 °C)(Found: C, 56-3; H, 5-25; N, 5-52. Calc, for 
Cu H10NO2S:C, 57-3; H, 5-2; N, 5-57%).
2-Butyne-4-(tetrahydropyranylopcy)-l-ol220 (249). To a suspension of
2-butyne-l,4-diol (10 g, 116 mmol) in dry dichloromethane (25 cm3) containing a 
catalytic amount of pyridinium p<zra-toluenesulphonate (2*76 g, 10 mmol) was 
added dihydropyran (13-9 g, 116 mmol) and the mixture was heated to 50-60 °C 
for 6 hours, cooled, washed with brine and extracted with ethyl acetate (3 x 30 
cm3), dried over sodium sulphate, and evaporated in vacuo to give a viscous 
yellow oil. Chromatography over silica gel, using ethyl acetate-light petroleum
(b.p. 60------80 °C)(1:1) as eluant afforded the diprotected alcohol (13.88 g, 70%)
and the monoprotected compound (4.07 g, 30%).
Monoprotected diol (249). umax. (CHC13) 3400 (OH), 2900 (CH) and 1302 cm' 1 
(CO); 5h (270 MHz; CDC13) 1*64 (6H, m, pyran), 3-26 (1H, s, OH), 3-56 (1H, m, 
CH20), 3-84 (1H, m, CH20), 4-29 (4H, s, (CH2)2Os), and 4 84 (1H, dd, /  3 and 
4 Hz, CH02); mlz CBuH Cl) 171 (MU  1,15%).
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Diprotected diol (251). v  (C H d3) 2900 (CH) and 1302 cm' 1 (CO); 5h (270 
MHz; CDCI3) 1-67 (12 H, m, pyran), 3-50 (2H, m, CH20), 3-83 (2H, m, CH20), 
4-28 (4H, s, (CH2)20 ) ,  4-81 (2H, s, CH02); mlz (;BuH a )  255 (M++1, 2%).
1-Butyne^-itetrahydropyranyloxyi-l-aP11 (248). To a solution of the
monoprotected alcohol (249) (0-385 g, 2-28 mmol) in dry dichloromethane (5 
cm3) containing 4-methylmorpholine N-oxide (0-4 g, 3-4 mmol) and 3 A 
molecular sieves stirred at room temperature, was added tetrapropylammonium 
perruthenate (TPAP)(5% mole 0.04 g, 0-11 mmol). This produced a dark 
green-black solution. After stirring for 1-5-2 hours all starting material had 
disappeared and a single component was observed by t.l.c. (ethyl acetate-light
petroleum (b.p. 60------80 °C)(1:4)). The reaction mixture was filtered through a
pad of silica gel, under nitrogen, to give the aldehyde (248)(0-2 g, 70% ) which 
was found to be unstable in air and was used directly in the following step, 
o max.(CHCl3) 2900 (CH) and 1700 cm' 1 (C = 0); 5h (270 MHz; CDC13) 1-69 (6H, 
m, pyran), 3-56 (1H, m, CH20 ) ,  3-83 (1H, m, CH20 ) ,  4-46 (2H, s, CH2C=), 4-81 
(1H, br t, C H 0 2) and 9-2 (1H, s, CHO); mlz (70 eV El) peak at 101 observed, 
corresponding to M++ 1 of the deprotected acid.
Attempted Formation of2-Butyne-4-(tetrahydropyranyloxy)-l-imine (247) and 
subsequent nucleophilic addition ofNitromethane. To a solution of
2-butyne-4-(tetrahydropyranyloxy)-l-al (248)(0-645 g, 3-8 mmol) in ethyl
acetate-light petroleum (b.p. 60------80 °C)(1:4) (20 cm3), containing magnesium
sulphate, was added an excess of methylamine in dry methanol (30 cm3). The 
reaction was allowed to warm slowly to room temperature for 2 hours and
145
sodium methoxide (0*2 g, 3-8 mmol) and nitromethane (0-2 g, 3*8 mmol) in dry 
dichloromethane (5 cm3) were added at -78 °C. The mixture was again allowed to 
warm slowly to room temperature, producing an orange-yellow solution. Solvents 
were removed and the resulting material was filtered through a pad of silica gel 
and washed with ethyl acetate as eluant (Rf 0-8) to give a red oil, which 
crystallised under reduced pressure to yield a crystalline solid (0-9 g, 70%), 
which proved to be the deprotected amide (252), \)max (CHCI3) 3450 (OH), 3350 
(NH) and 1740 cm' 1 (NHC=0); 8h (270 MHz; CDC13) 2 0 (3H, s, CH3N), 2-76 
(1H, s, OH), 2*78 (2H, d, /  5 Hz, CH2OH) and 7-60 (1H, s, NH); 8C (68 MHz; 
CDCI3) 25 0 (CH2OH), 25-6 (CH3N), 61-9 (teC C =0), 96 (C=CCH2) and 173-7 
(CH3NC=0); mlz (70 eV El) 113 (Af+, 2%).
Formation o f a Nitroamine (254) from Isobutyraldehyde (253).------To a solution
of isobutyraldehyde (1 g, 13-8 mmol), in dry dichloromethane (10 cm3), was
added magnesium sulphate and methylamine and the resulting solution was
stirred at room temperature for 20 hours. Freshly distilled nitromethane (0-84 g,
13-8 mmol) and sodium methoxide (0-84 g, 13-8 mmol) were added and the
mixture was heated for 20 hours at 70-80 °C. Solvent was evaporated to give an
orange solution which was filtered through a pad of silica gel and eluted with
*
ethyl acetate-light petroleum (b.p. 60------80 °C)(1:1) to yield a pale yellow oil
nitroamine (254)(0-65 g, 30%), umM. (CHC13) 3300 (NH) and 1560 cm’1 (N02); 
5h (270 MHz; CDC13) 1 0  (6H, dd, /  7 Hz, (C//3)2CH), 1 -92 (1H, m, 
(CH3)2CHCHCH2) and 4-4 (2H, m, N 02CH2CH); mlz (70 eV El) 145 (Af+, 2%).
Methyl 1-hydroxypentanoate (256). To a solution of 8-valerolactone (01 g,
0-99 mmol) in dry methanol (20 cm3) under nitrogen was added sodium
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methoxide (0-16 g, 3 mmol), the mixture was heated to reflux for 5 hours, cooled, 
and acidified to pH 2 with 2M hydrochloric acid. Excess methanol was removed 
by evaporation in vacuo, the residue was extracted with ethyl acetate (3 x 50 
cm3), dried over magnesium sulphate and evaporated to give a pale yellow oil 
(0-1 g, 95%) which did not require further purification, nmax (CHC13) 3400 (OH), 
and 1720 cm' 1 (C=0); 5h (270 MHz; CDC13) 1-9 (2H, m, Cff2CH2CO), 2-3 (2H, 
m, C//2CH2OH), 2-5 (2H, t, /  7 Hz, CH2CO), 2-8 (1H, br, OH) and 3-6 (5H, s 
and t, /  6 Hz, CH30  and CH2OH); mlz CBuH Cl) 133 (M++1, 50%).
Methyl 5-formylpentanoate (257). To a solution of penanoate (256) (0.05 g,
0-56 mmol) in dry dichloromethane (5 cm3) was added powdered 3A molecular 
sieves, N-morpholine TV-oxide (0.06 g, 0-56 mmol) and 5% mole of 
tetrapropylammonium perruthenate (0-6 g, 0-02 mmol). The mixture gave a 
bottle-green coloured solution, which was stirred at room temperature for 1 hour, 
then filtered through a pad of silica gel and eluted with ethyl acetate, to yield the 
aldehyde as a pale yellow oil (20 mg, 42%), uma3L (CHC13) 1720 (C=0) and 1650 
cm’1 C=0); 8h (270 MHz; CDC13) 1-98 (2H, m, C//2CH2C=0), 2-35 (2H, m, 
C//2CH2OH), 2-56 (2H, t, / 7  Hz, CH2CO), 3-68 (3H, s, CH3OCO) and 9-77 
(1H, s, CHO); mlz (70 eV El) 130 (M+, 2%).
Attempted Reaction between Nitromethane Anion and the Imine formed from
Methyl 5-formylpentanoate. To a solution of the aldehyde (0*05 g, 0-38
mmol) in dichloromethane (5 cm3), containing magnesium sulphate, was added 
an excess of methylamine gas and the solution was stirred overnight to ensure 
complete formation of the imine. Freshly distilled nitromethane (0-2cm3, 3*69 
mmol) and sodium methoxide (0-2 g, 3 *69 mmol) were added, and the reaction
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mixture was refluxed for 5 hours, under nitrogen, giving an orange solution. The 
excess solvent was evaporated and the mixture was acidified and filtered to 
remove inorganic material. The filtrate was extracted with ethyl acetate (3 x 20 
cm3), dried over magnesium sulphate, and evaporated to give an orange-brown 
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